EN


National Institute for Biological Standards and Control (NIBSC), 英国国家标准局,是WHO指定的国际标准品供应商,常规产品大量备货;我司是其国内主要的代理分销商,所有采购产品合规进口,溯源可查,质量保障。

Vendor Product Number Description
NIBSC 00/410 MAPREC assay of poliovirus type 1 (Sabin).100% 480-A, 525-C DNA(1st International Reference Preparation)
NIBSC 00/416 Low Mutant Virus Reference for MAPREC assay of poliovirus type 1 (Sabin)(1st International Reference Preparation)
NIBSC 00/418 MAPREC assay of poliovirus type 1 (Sabin) (1st International Standard)
NIBSC 00/422 High Mutant Virus Reference for MAPREC assay of poliovirus type 1 (Sabin)(1st International Reference Preparation)
NIBSC 00/440 Influenza Antiserum A/Singapore/1/57 (H2)
NIBSC 00/442 Influenza anti B/Yamanashi/166/98 Serum
NIBSC 00/498 Diphtheria Antitoxin Human IgG
NIBSC 00/500 Botulinum Type A-E Antitoxin, Human Serum
NIBSC 00/542 Influenza anti- A/Chick/Scotland/59 (H5N1) Serum
NIBSC 00/546 Influenza Antigen B/Johannesburg/5/99
NIBSC 00/552 Influenza Antigen A/Duck/Singapore-Q/F119-3/97 (H5N3)
NIBSC 00/556 Influenza anti-B/Johannesburg/5/99/ Serum
NIBSC 00/572 Interferon Beta (Human, rDNA, Glycosylated) (3rd International standard)
NIBSC 00/574 Interferon Beta SER17 Mutein (Human, rDNA derived)
NIBSC 00/576 Interferon Beta (Human, Fibroblast-derived, Glycosylated)
NIBSC 007SP Human Anti-Pneumococcal capsule Reference Serum (1st International Standard)
NIBSC 01/412 Anti-Meningococcal Immunotype L3,7,9 Monoclonal Antibody
NIBSC 01/420 Interleukin-17 (Human rDNA derived)(WHO Reference Reagent)
NIBSC 01/426 Meningococcal group Y polysaccharide
NIBSC 01/428 Meningococcal serogroup W polysaccharide
NIBSC 01/450 Influenza anti B/Guangdong/120/2000 Serum
NIBSC 01/452 Influenza anti A/Panama/2007/99 (H3N2) HA serum
NIBSC 01/506 Botulinum type F antitoxin, equine
NIBSC 01/508 Botulinum type C antitoxin, equine
NIBSC 01/510 Botulinum Antitoxin Equine Type D
NIBSC 01/512 Botulinum type G antitoxin, equine
NIBSC 01/514 Anti-Meningococcal Serosubtype P1.7 Monoclonal Antibody
NIBSC 01/538 Anti-Meningococcal Serosubtype P1.16 mAb
NIBSC 01/546 Influenza Antigen B/Guangdong/120/2000
NIBSC 01/580 Thrombin, human(2nd International Standard)
NIBSC 01/600 Anti-Toxoplasma IgG, Human(International Standard)
NIBSC 01/602 Anti-Parvovirus B19, plasma, human(2nd International Standard)
NIBSC 01/612 Influenza Virus infectious B/Hawaii/10/01
NIBSC 01/614 Influenza Antigen A/New Caledonia/20/99
NIBSC 02/102 Influenza anti A/Panama/2007/99 Serum
NIBSC 02/144 Anti-Meningococcal Serosubtype P1.15 mAb
NIBSC 02/148 Anti-Meningococcal Serosubtype P1.4 mAb
NIBSC 02/178 Anti-Meningococcal Serosubtype P1.2 mAb
NIBSC 02/180 Anti-Meningococcal Serotype P2.2a mAb
NIBSC 02/182 Anti-Japanese Encephalitis Virus Plasma, Human
NIBSC 02/184 Anti-Japanese Encephalitis (Anti-JE) Virus Negative Control Plasma, Human
NIBSC 02/206 Factor XIII Plasma, Human (1st International Standard)
NIBSC 02/210 HIV (antibody), 1st International Reference Panel
NIBSC 02/226 IVIG negative control for use with IVIG + anti-D(WHO Reference Reagent)
NIBSC 02/228 IVIG + anti-D for use with negative control IVIG(WHO Reference Reagent)
NIBSC 02/230 Biotinylated Brad-5 (Bio-Brad-5)
NIBSC 02/232 Tetanus Toxoid (Non-Adsorbed)
NIBSC 02/286 Vascular Endothelial Growth Factor 165 (VEGF165)(recDNA, human sequence)(WHO Reference Reagent)
NIBSC 02/294 Influenza Antiserum A/chick/Italy/1347/99 (H7N1)
NIBSC 02/308 Anti-Meningococcal Serotype P3.4 mAb
NIBSC 02/310 Anti-Meningococcal Serotype P3.15 mAb
NIBSC 02/318 Botulinum Antitoxin Equine Type E
NIBSC 02/320 Anti-Meningococcal Serosubtype P1.3 mAb
NIBSC 02/336 Influenza Antigen A/New Caledonia/20/99
NIBSC 02/338 Influenza anti A/Panama/2007/99 Serum
NIBSC 02/342 Protein C Plasma, Human(2nd International Standard)
NIBSC 03/104 HTLV-1 (antibody) Monitor Sample
NIBSC 03/110 Influenza anti B/Shangdong/9/97 Serum
NIBSC 03/114 Anti-Meningococcal Serosubtype P1.1 mAb
NIBSC 03/124 Thrombopoietin ( Human rDNA derived)
NIBSC 03/142 Anti-Meningococcal Serosubtype P1.14 mAb
NIBSC 03/148 Keratinocyte growth factor (KGF, FGF-7)(24-163)(1st WHO Reference Reagent)
NIBSC 03/150 Keratinocyte Growth Factor (KGF,FGF-7)(1st WHO Reference Reagent)
NIBSC 03/152 Anti-HPA-1a (International Standard)
NIBSC 03/164 Anti-B minimum potency reference preparation(International Standard)
NIBSC 03/178 Vitamin B12, Serum Folate and holoTC (International standard)
NIBSC 03/182 Anti-Meningococcal Serotype P3.21 mAb
NIBSC 03/188 Anti-A minimum potency reference preparation(International Standard)
NIBSC 03/190 Anti-HPA-3a(minimum potency)(WHO Reference Reagent)
NIBSC 03/192 Thyroid-Stimulating Hormone, Recombinant, Human, for Bioassay (1st International standard)
NIBSC 03/200 Interleukin - 18 (Human rDNA derived)(WHO Reference Reagent)
NIBSC 03/210 Anti-Meningiococcal Serosubtype P1.6 mAb
NIBSC 03/212 Influenza anti A/Wyoming/03/03 Serum
NIBSC 03/220 Influenza Antigen A/Wyoming/03/03
NIBSC 03/224 Anti-Meningococcal Serosubtype P1.10 mAb
NIBSC 03/226 Anti-Meningococcal Serosubtype P1.5 mAb
NIBSC 03/228 Protein S, Plasma, Human(2nd International Standard)
NIBSC 03/236 Anti-Meningococcal Serosubtype P1.13 mAb
NIBSC 03/242 Influenza anti A/Puerto Rico/8/34 (H1N1) HA Serum
NIBSC 03/244 Influenza Antiserum A/chick/Germany/N/49
NIBSC 03/258 Influenza Antigen A/New Caledonia/20/99 (IVR-116)
NIBSC 03/262 Hepatitis B Surface Antigen subtype adw2, genotype A (International Reference Panel)
NIBSC 04/122 Anti-Meningococcal Serosubtype P1.12 mAb
NIBSC 04/160 Influenza Virus infectious NYMC X-147
NIBSC 04/166 TNF-related Apoptosis-Inducing Ligand (trail), Human, rDNA-derived(1st WHO Reference Reagent)
NIBSC 04/170 Influenza Virus infectious A/Wellington/1/2004
NIBSC 04/172 Influenza Virus infectious IVR-139
NIBSC 04/176 Plasmodium falciparum DNA for NAT Assays(1st International Standard)
NIBSC 04/198 Anti-Meningococcal Serotype P3.1 mAb
NIBSC 04/202 Influenza Antigen B/ Jiangsu/10/2003
NIBSC 04/224 Factor V Leiden, Human gDNA, 1st International Genetic Reference Panel 2004
NIBSC 04/228 Influenza anti B/ Neuraminidase Serum
NIBSC 04/242 Influenza anti B/Jiangsu/10/2003 HA Serum
NIBSC 04/246 Anti-Meningococcal Serogroup W-135 mAb
NIBSC 04/248 Anti-Meningococcal Serosubtype P1.19 mAb
NIBSC 04/252 Protein C Concentrate, Human(1st International Standard)
NIBSC 04/260 Influenza anti A/New Caledonia/20/99 HA Serum
NIBSC 04/262 Influenza anti A/New York/55/2004 HA Serum
NIBSC 04/264 Influenza Antigen A/New York/55/2004 (H3N2) (NYMC X-157)
NIBSC 05/102 Influenza Virus infectious NYMC BX-7
NIBSC 05/106 Anti-HPA-1a minimum potency reagent(2nd WHO Reference reagent)
NIBSC 05/112 Low Molecular Weight Heparin for Molecular Weight Calibration (2nd International Standard).
NIBSC 05/130 Prothrombin Mutation G20210A, Human gDNA(1st International Genetic Reference Panel 2005)
NIBSC 05/134 Anti-human papillomavirus type 16 serum (1st International Standard)
NIBSC 05/162 Alpha-1-Antitrypsin, plasma derived(1st International standard)
NIBSC 05/190 Anti Meningococcal Serosubtype P1.9 Monoclonal Antibody
NIBSC 05/192 Anti Meningococcal Serotype P2.2b Monoclonal Antibody
NIBSC 05/234 Influenza Antigen A/Hiroshima/52/2005 (H3N2) (IVR-142)
NIBSC 05/236 Influenza anti A/Wisconsin/67/2005 Serum
NIBSC 05/252 Influenza anti B Neuraminidase Serum
NIBSC 06/108 Influenza Virus infectious IVR-116
NIBSC 06/124 Monoclonal Antibody for Serotyping Bordetella pertussis Fimbrial Antigen 2 (1st International Standard)
NIBSC 06/128 Monoclonal Antibody for Serotyping Bordetella pertussis Fimbrial Antigen 3 (1st International Standard)
NIBSC 06/140 Pertussis Antiserum(human)1st IS-WHO international Standard.
NIBSC 06/142 Pertussis Antiserum (Human) 1st WHO Reference Reagent
NIBSC 06/164 Influenza Virus infectious 1 VR-142
NIBSC 06/166 Antithrombin Concentrate, Human (3rd International Standard)
NIBSC 06/170 Influenza Antigen A/New Caledonia/20/99
NIBSC 06/192 Influenza anti A/turkey/Turkey/1/05 (NIBRG-23) HA serum(sheepSH465 & SH466)
NIBSC 06/202 Human Papillomavirus (HPV) Type 16 DNA (1st International Standard)
NIBSC 06/206 Human Papillomavirus (HPV) Type 18 DNA (1st International Standard)
NIBSC 06/242 Influenza Virus Infectious NYMC X-161B (A/Wisconsin/67/2005 HGR)
NIBSC 07/102 Influenza Antigen A/Solomon Islands/3/2006 (H1N1)(IVR-145)
NIBSC 07/104 Influenza anti A/Solomon Islands/3/2006 (H1N1) (IVR-145) HA Serum
NIBSC 07/112 Influenza Antigen A/turkey/Turkey/1/2005 (H5N1) NIBRG-23
NIBSC 07/132 Influenza Virus infectious B/Malaysia/2506/2004
NIBSC 07/144 Influenza Virus infectious IVR-145,
NIBSC 07/146 Influenza anti A/HongKong/1073/99 like (H9) HA Serum (sheep)
NIBSC 07/148 Influenza anti A/Vietnam/1194/04 (H5N1) HA Serum
NIBSC 07/150 Human Plasma Anti-Influenza H5N1 (1st International Standard)
NIBSC 07/164 Anti-hepatitis B surface antigen(Anti-HBs) immunoglobulin (2nd International Standard)
NIBSC 07/184 Influenza anti B/Malaysia/2506/2004-HA Serum
NIBSC 07/202 Recombinant soluble transferrin receptor (rsTfR)(1st WHO Reference Reagent)
NIBSC 07/214 Positive Control for use in flow cytometry cross matching (FCXM)
NIBSC 07/216 Diphtheria Toxoid (Adsorbed) (4th International Standard)
NIBSC 07/222 RhD/SRY Plasma DNA sensitivity standard (1st WHO Reference Reagent)
NIBSC 07/228 Blood Coagulation Factor VIIa, Concentrate, Human, 2nd International Standard鈥
NIBSC 07/270 BCG Vaccine of Danish 1331 sub-strain (1st WHO Reference Reagent)
NIBSC 07/272 BCG Vaccine of Tokyo 172 sub-strain(1st WHO Reference Reagent)
NIBSC 07/274 BCG Vaccine of Russian BCG-I sub-strain(1st WHO Reference Reagent)
NIBSC 07/278 Influenza anti A/mallard/Netherlands/12/2000 (H7) HA serum (NIBRG-60) (sheep SH474 AND SH475)
NIBSC 07/286 Monitor sample for HBsAg 0.05IU/ml
NIBSC 07/288 Hepatitis B Surface Antigen (HBsAg) British Working Standard 0.2 IU/ml
NIBSC 07/290 Influenza Antigen A/Anhui/1/05 (H5N1) IBCDC-RG-6
NIBSC 07/296 Influenza Virus (A/Christchurch/1/2003, H1N1) for Nucleic Acid Amplification Techniques
NIBSC 07/298 Influenza Virus (A/Wyoming/3/2003, H3N2) for Nucleic Acid Amplification Techniques
NIBSC 07/300 Influenza Virus (B/Jiangsu/10/2003) for Nucleic Acid Amplification Techniques
NIBSC 07/304 Anti-D for assuring operator and test performance
NIBSC 07/306 Anti-A and anti-B in IVIG: Positive control for haemagglutination tests (WHO Reference Reagent)
NIBSC 07/316 Blood Coagulation Factor VIII and Von Willebrand Factor in Plasma (6th I.S.)
NIBSC 07/318 Meningococcal Group C Polysaccharide
NIBSC 07/328 Unfractionated Heparin (6th I.S.)
NIBSC 07/336 Influenza Antigen A/mallard/Netherlands/12/00(H7N3) NIBRG-60
NIBSC 07/338 Influenza antiserum A/Anhui/1/05 (H5)
NIBSC 07/348 Influenza Virus infectious NYMC X-171B
NIBSC 07/350 Blood Coagulation Factor VIII Concentrate (8th I.S.)
NIBSC 07/358 Influenza Virus infectious NIB-50
NIBSC 07/362 Influenza Virus infectious IVR-149
NIBSC 07/B498 QCRHBclgMQC1-IgM Anti-HBc Quality Control Serum: Sample1
NIBSC 08/100 Influenza Antigen A/Brisbane/59/2007 (IVR-148) (H1N1)
NIBSC 08/108 Influenza Virus Infectious NIBRG-91 (H9N2)
NIBSC 08/118 Parainfluenza Virus serotype 3 for Nucleic Acid Amplification Techniques
NIBSC 08/120 Human Respiratory syncytial virus A2 for Nucleic Acid Amplification Techniques
NIBSC 08/126 Influenza Anti N1 Neuraminidase Serum SH485
NIBSC 08/138 Influenza Virus Infectious B/Florida/4/2006
NIBSC 08/140 Influenza Antigen B/Florida/4/2006
NIBSC 08/142 Influenza antiserum A/Anhui/1/05 (H5)
NIBSC 08/148 Positive control for Luminex based anti-HLA Class II serology
NIBSC 08/156 Influenza Virus Infectious NIBRG-23 30060 VE3 (H5N1)
NIBSC 08/158 Fragile X Syndrome gDNA (1st International Genetic Reference Panel)
NIBSC 08/160 Haemophilia A, Intron-22 inversion, gDNA, (1st International Genetic Reference Panel)
NIBSC 08/174 Human Coxsackie B4 for Nucleic Acid Amplification Techniques
NIBSC 08/176 Parainfluenza Virus serotype 1 for Nucleic Acid Amplification Techniques
NIBSC 08/178 Parainfluenza Virus serotype 2 for Nucleic Acid Amplification Techniques
NIBSC 08/180 Parainfluenza virus serotype 4 for Nucleic Acid Amplification Techniques
NIBSC 08/184 Influenza Antigen B/Malaysia/2506/2004
NIBSC 08/202 Influenza anti A/chick/Hong Kong/G9/1997/(H9) HA serum (NIBRG-94)(H9N1)
NIBSC 08/204 Thyroid Stimulating Antibody (2nd I.S.)
NIBSC 08/208 Influenza Antigen Hong Kong/1073/99 (H9N2)
NIBSC 08/210 Influenza anti A/Cambodia/R0405050/2007 (H5) HA serum (NIBRG-86)
NIBSC 08/214 Meningococcal Serogroup C polysaccharide (1st International Standard)
NIBSC 08/216 Influenza Antigen A/Cambodia/RO405050/2007 (H5N1)
NIBSC 08/218 Tetanus Toxoid Adsorbed (4th International Standard)
NIBSC 08/228 Influenza Antigen A/chick/Hong Kong/G9/1997 (H9N2) NIBRG-91
NIBSC 08/230 Streptodornase (2nd International Standard)
NIBSC 08/246 Influenza anti A/Brisbane/10/2007- like HA serum
NIBSC 08/248 Influenza Virus Infectious NIBRG-107 VE2 30480
NIBSC 08/250 Influenza Virus Infectious NIBRG-63 VE2 30500 (H7N1)
NIBSC 08/252 Influenza Virus Infectious NIBRG-109 VE2 30490
NIBSC 08/256 C1- Inhibitor, Concentrate (1st International Standard)
NIBSC 08/258 Antithrombin, Plasma (3rd International Standard)
NIBSC 08/262 C1 Inhibitor (Plasma)(1st International Standard)
NIBSC 08/266 Sex Hormone Binding Globulin.(2nd International Standard)
NIBSC 08/268 Influenza Antigen A/mallard/England/727/2006 (H2N3)NIBRG-107
NIBSC 08/278 Influenza Antigen A/Brisbane/10/2007-like (Prepared from A/Uruguay/716/2007 (NYMC X-175C))
NIBSC 08/282 Follicle-Stimulating Hormone, human, recombinant, for bioassay (2nd International Standard)
NIBSC 08/298 Influenza Virus Infectious B/Brisbane/33/2008 30720 E5
NIBSC 08/300 Influenza Virus Infectious IVR-148
NIBSC 08/304 Influenza virus infectious NYMC X-175C
NIBSC 08/318 Human Norovirus GI Working Reagent for Nucleic Acid Amplification Testing
NIBSC 08/320 Human Metapneumovirus Working Reagent for Nucleic Acid Amplification Testing
NIBSC 08/322 Human Parechovirus Working Reagent for Nucleic Acid Amplification Testing
NIBSC 08/324 Human Rhinovirus Genogroup A Working Reagent for Nucleic Acid Amplification Testing
NIBSC 08/356 Influenza antiserum A/Japan/305/57 (H2)
NIBSC 08/362 Influenza Antigen A/New York/107/2003 (H7N2)NIBRG-109
NIBSC 09/100 Influenza anti A/mallard/England/727/2006 (N3) NA serum (NIBRG-107) (Sheep SH503)
NIBSC 09/110 Parvovirus B19 DNA Nucleic Acid Amplification Technology(NAT) based assays Genotype Panel(1st International Standard)
NIBSC 09/130 Influenza Virus Infectious NIBRG-122
NIBSC 09/132 Human Coronavirus 229E Working Reagent for Nucleic Acid Amplification Testing
NIBSC 09/136 Granulocyte Colony Stimulating Factor (Human, rDNA Derived)(2nd International Standard)
NIBSC 09/138 Genetic Reference Panel, for the quantitation of BCR-ABL translocation by RQ-PCR (1st I.S.)
NIBSC 09/140 Prader Willi & Angelman Syndromes, Human gDNA,(1st International Genetic Reference Panel)
NIBSC 09/148 Influenza anti A/New York/107/2003 (H7) HA serum (Sheep SH504 and SH505)
NIBSC 09/162 Human Cytomegalovirus (HCMV) for Nucleic Acid Amplification Techniques (1st International Standard)
NIBSC 09/170 Anti-Meningococcal factor H binding protein variant 1 (JAR4) monoclonal antibody
NIBSC 09/172 Blood coagulation Factors II, VII, IX, X Plasma (4th International Standard 2010)
NIBSC 09/174 Influenza Antigen A/California/7/09 (H1N1)v (NYMCX-179A)(Cell Derived)
NIBSC 09/182 VWF Factor Concentrate (2nd International Standard)
NIBSC 09/184 Influenza Antigen A/Vietnam/1194/2004 (H5N1) NIBRG-14
NIBSC 09/186 Chagas (anti-Trypanosoma cruzi II) antibody in human plasma(1st International Standard)
NIBSC 09/188 Chagas (anti-Trypanosoma cruzi I) antibody in Human Plasma (1st International Standard)
NIBSC 09/196 Influenza Antigen A/California/7/09 (H1N1)v (NIBRG-121xp) (Egg Derived)
NIBSC 09/222 Human anti-Haemophilus influenzae b reference serum
NIBSC 09/234 Transforming Growth Factor-BETA 3 (Human, rDNA derived TGF-脽 3) (1st International Standard)
NIBSC 09/236 Influenza Virus Infectious IVR-153
NIBSC 09/242 Fibrinogen Concentrate (B)(2nd International Standard)
NIBSC 09/260 Epstein-Barr Virus for Nucleic Acid Amplification Techniques(1st International Standard)
NIBSC 09/264 Fibrinogen Plasma (D)(3rd International Standard)
NIBSC 09/266 GLIAL CELL-DERIVED NEUROTROPHIC FACTOR (GDNF), human, rDNA-derived
NIBSC 09/268 Influenza Virus Infectious NIBRG-121xp
NIBSC 09/272 Placental growth factor Ala 21 - Arg 149, human, rDNA-derived (PlGF, PlGF-1)
NIBSC 09/274 Influenza Virus Infectious NYMC X-185
NIBSC 09/280 Influenza Virus Infectious NIB-64
NIBSC 09/284 Anti-Human Neutrophil Antibody 1a WHO Reference Reagent
NIBSC 09/296 Pro-Insulin, human (1st International Standard)
NIBSC 09/304 Influenza Virus Infectious IVR-155
NIBSC 09/306 Influenza Virus Infectious NIBRG-147 (H2N2)
NIBSC 09/308 Influenza Serology Antigen Reagent X-179A (H1N1pdm) for HI Assay
NIBSC 09/310 Influenza Antigen A/Wisconsin/15/09 (H3N2) (NYMCX-183)
NIBSC 09/316 Influenza Anti B Neuraminidase Serum (B/Florida/4/2006)
NIBSC 10/104 Reteplase Reference Material
NIBSC 10/120 Influenza Anti A/Brisbane/59/2007 (IVR 148)(H1N1) HA serum
NIBSC 10/128 Diphtheria Polyclonal Antibody
NIBSC 10/130 Diphtheria Monoclonal Antibody
NIBSC 10/132 Tetanus Polyclonal Antibody
NIBSC 10/134 Tetanus Monoclonal Antibody
NIBSC 10/140 Anti-human papillomavirus[HPV] 18 serum (1st International Standard)
NIBSC 10/142 Negative control for Luminex based anti-HLA serology
NIBSC 10/164 Oral Poliovaccine Sabin Type 1 reference strain [LS-c, 2ab strain].
NIBSC 10/168 Oral Poliovaccine Sabin Type 3 reference
NIBSC 10/176 Interleukin-29 (Interferon Lambda, Human, rDNA derived) WHO Reference Reagent
NIBSC 10/178 Endotoxin (3rd International Standard)
NIBSC 10/198 Anti-malaria (Plasmodium falciparum) human serum(1st WHO Reference Reagent)
NIBSC 10/202 Influenza antibody (Human) to A/California/7/2009 'like' (H1N1v) virus (2nd International Standard)
NIBSC 10/214 Influenza Anti N2 Neuraminidase Serum SH395 & SH396
NIBSC 10/218 Influenza Anti A/California/7/2009 (N1) NA Serum
NIBSC 10/226 Influenza Virus Infectious IVR-158
NIBSC 10/232 Blood Group Genotyping Reference Reagent RBC1 (OR1R2)(WHO Reference Reagent)
NIBSC 10/234 Blood Group Genotyping Reference Reagent RBC12 (ODpsi)(WHO Reference Reagent)
NIBSC 10/236 Blood Group Genotyping Reference Reagent RBC4 (AR1R1)(WHO Reference Reagent)
NIBSC 10/238 Blood Group Genotyping Reference Reagent RBC5 (Brr)(WHO Reference Reagent)
NIBSC 10/242 Toxoplasma gondii DNA Nucleic Acid Amplification Techniques(1st International Standard)
NIBSC 10/252 Factor VII Concentrate (2nd International Standard)
NIBSC 10/258 Influenza Antigen A/California/7/2009-like(NIB-74)
NIBSC 10/262 Diphtheria Antitoxin Human IgG(1st International Standard)
NIBSC 10/266 4th WHO International Standard for HBV DNA for NAT
NIBSC 10/272 BCG vaccine of Moreau-RJ sub-strain(1st WHO Reference Reagent)
NIBSC 10/286 Follicle Stimulating Hormone, Luteinizing Hormone human, urinary for bioassay(5th International Standard)
NIBSC 10/B596 QCRHSV1QC1-Anti-HSV1 Quality Control Serum: Sample1
NIBSC 1050 IPV ELISA MAbs Type 1, 2 and 3 (Type 2; No: 1050)
NIBSC 11/108 Influenza Virus infectious NYMC X-187
NIBSC 11/126 Factors II and X Concentrate (4th International standard)
NIBSC 11/130 Influenza Virus Infectious NIBRG-14 (H5N1)
NIBSC 11/134 Influenza Antigen A/California/7/2009 (H1N1) Like (A/Brisbane/10/2010- cell derived)
NIBSC 11/170 Erythropoietin, recombinant, for Bioassay (3rd International Standard)
NIBSC 11/176 (3rd International Standard) Low Molecular Weight Heparin
NIBSC 11/184 High Molecular Weight Urokinase(2nd International Standard)
NIBSC 11/206 Influenza anti-A/Perth/16/2009 HA Serum
NIBSC 11/210 Anti-human CD4 FITC conjugated 0.5ml
NIBSC 11/212 Biosynthetic Human Insulin (2nd WHO international Standard)
NIBSC 11/214 Blood Group Genotyping Reference Reagents Panel (WHO Reference Reagent)
NIBSC 11/216 Chagas Antibody Reference Panel ( 1st International Standard)
NIBSC 11/218 MLH1/MSH2 Exon Copy Number Reference Panel
NIBSC 11/222 Influenza Virus Infectious NIB-79
NIBSC 11/232 Influenza Virus Infectious B/Texas/6/2011
NIBSC 11/234 Immunoglobulin E(IgE) human serum (3rd International Standard)
NIBSC 11/242 Viral Multiplex Reference
NIBSC 11/244 Influenza Virus Infectiious NYMC BX-49
NIBSC 11/B608 QCRHIV1QC1-Anti-HIV1:Quality Control Serum: Sample1
NIBSC 12/100 Influenza Virus Infectious NYMC X-217
NIBSC 12/104 International Standard for IPV 12/104 (3rd International Standard)
NIBSC 12/106 Influenza Antigen B/Hubei-Wujiagang/158/2009 (NYMCBX-39)
NIBSC 12/110 Influenza Antigen B/Wisconsin/1/2010 (cell derived)
NIBSC 12/112 Influenza Antigen A/Victoria/210/2009 (H3N2) (NYMCX-187)
NIBSC 12/114 Influenza Antigen A/Victoria/361/2011 (H3N2) (IVR-165)
NIBSC 12/116 Influenza anti-A/Victoria/361/2011-like HA serum
NIBSC 12/118 Influenza anti-B/Wisconsin/1/2010-like HA serum
NIBSC 12/122 Influenza virus infectious A/turkey/Italy/3889/1999 (H7N1)
NIBSC 12/154 Tumour Necrosis Factor alpha (human rDNA derived)(3rd International Standard)
NIBSC 12/176 Methylated Human Serum Albumin (mHSA)
NIBSC 12/188 Pegylated Granulocyte Colony Stimulating Factor (Human, rDNA derived) (1st International Standard)
NIBSC 12/198 Influenza virus infectious B/Wisconsin/1/2010 34490 E5
NIBSC 12/202 Influenza virus infectious NYMC BX-39
NIBSC 12/204 Influenza Virus infectious IVR-165
NIBSC 12/208 Parvovirus B19 (3rd International Standard)
NIBSC 12/224 HIV-1 NAT subtypes (Main)(2nd International Reference Panel Preparation)
NIBSC 12/226 HBsAg (HBV genotype B4, HBsAg subtypes ayw1/adw2)(3rd International Standard)
NIBSC 12/244 Vi polysaccharide of C freundii WHO 1st International Standard
NIBSC 12/252 ADAMTS 13 Plasma (1st International Standard)
NIBSC 12/278 2nd Pneumococcal QC Serum Panel
NIBSC 12/282 Diphtheria Toxin 1Lf/ml
NIBSC 12/284 Anti-meningococcal serogroup Y monoclonal antibody
NIBSC 12/290 Influenza Virus Infectious B/Brisbane/36/2012
NIBSC 12/294 Influenza Virus Infectious NYMC BX-51C
NIBSC 12/300 Negative Control IVIG (for use with IVIG and Anti-D)
NIBSC 12/306 Haemophilus Influenzae Polysaccharide Polyribosyl Ribitol Phosphate (PRP)(2nd International Standard)
NIBSC 12/B611 Anti-VZV Quality control serum: Sample 1 QCRVZVIgMQC1
NIBSC 12/B612 QCRRUBIgMQC1-Anti-Rubella IgM Quality Control Serum: Sample 1
NIBSC 13/100 Activated Blood Coagulation Factor XI (FXIa), Human (1st International Standard)
NIBSC 13/106 Influenza Antigen B/Massachusetts/02/2012
NIBSC 13/108 Anti-Meningococcal serogroup B monoclonal antibody
NIBSC 13/112 Influenza Antigen A/Texas/50/2012 (NYMC X-223)
NIBSC 13/116 Influenza Antigen A/Texas/50/2012 (NYMC X-223A)
NIBSC 13/122 Erythropoietin Antibody Reference Panel Negative Control Antibody (1st WHO Reference Panel)
NIBSC 13/126 Influenza anti-B/Brisbane/60/2008-like HA serum
NIBSC 13/128 Influenza Virus Infectious NIBRG-269
NIBSC 13/132 Antibodies, Human, to Toxoplasma gondii (4th International Standard).
NIBSC 13/134 Influenza Antigen B/Massachusetts/02/2012 (Egg derived)
NIBSC 13/146 C-Peptide, Human (1st International Standard).
NIBSC 13/148 IVIG + anti-D for use with negative control IVIG
NIBSC 13/152 Influenza Antigen B/Massachusetts/02/2012 (Cell Derived)
NIBSC 13/162 Influenza Antigen A/Texas/50/2012 (NYMC X-223A) (Cell derived)
NIBSC 13/164 Influenza Antigen A/California/7/2009 (H1N1pdm)(NYMC X-179A)
NIBSC 13/166 Influenza anti-A/Anhui/1/2013 (N9) NA Serum
NIBSC 13/168 Human Measles Mvi/Moscow Rus/1988 Genotype A Virus for Nucleic Acid Amplification Techniques
NIBSC 13/172 Lupus Anticoagulant (1st International Reference Panel)
NIBSC 13/176 Influenza Virus Infectious NIBRG-88
NIBSC 13/178 Influenza Anti-A/Texas/50/2012-like HA Serum
NIBSC 13/182 Influenza Anti-B/Massachusetts/02/2012-like HA Serum
NIBSC 13/200 Influenza Virus Infectious NIB-74
NIBSC 13/202 Influenza Virus Infectious NIB-74xp
NIBSC 13/204 TNF Rec II- FC Fusion protein (1st International Standard)
NIBSC 13/206 Plasmin (4th International Standard)
NIBSC 13/212 Diphtheria Toxoid for use in Flocculation Test (3rd International Standard)
NIBSC 13/214 HIV-1 Circulating Recombinant Forms RNA (1st International Reference Panel)
NIBSC 13/216 Anti-meningococcal factor H binding protein variant 1 (JAR5) monoclonal
NIBSC 13/218 Polio Anti Sabin type 1 (inactivated) Serum
NIBSC 13/220 Polio Anti Sabin type 2 (inactivated) serum
NIBSC 13/222 Polio Anti Sabin type 3 (inactivated) serum
NIBSC 13/224 Influenza virus Infectious NIB-85. 36210 E5
NIBSC 13/228 Influenza Virus Infectious. A/Almaty/2958/2013. 35790 E4
NIBSC 13/234 Influenza antigen B/Brisbane/60/08
NIBSC 13/238 Anti-EV71 serum LOW (WHO Reference Reagent)
NIBSC 13/240 Tetanus Immunoglobulin, Human (2nd WHO International Standard)
NIBSC 13/242 FEIBA Concentrate 2nd NIBSC Working Reference Standard
NIBSC 13/246 Meningococcal serogroup A polysaccharide (1st WHO International Standard).
NIBSC 13/248 Influenza virus infectious NIBRG-267 (H7N9)
NIBSC 13/250 Influenza Virus Infectious NIBRG-268 (H7N9)
NIBSC 13/252 Influenza virus infectious NYMC X-223A
NIBSC 13/256 Influenza virus infectious. NYMC x-233
NIBSC 13/258 Influenza virus infectious NYMC X-233A
NIBSC 13/262 Meningococcal serogroup A polysaccharide
NIBSC 13/264 Influenza Virus Infectious NYMC X-223
NIBSC 13/B627 QCRMALQC1-Anti-Malaria Quality Control Serum: Sample1
NIBSC 13/B629 QCRHBeQC1-Anti-HBe Quality Control Serum: sample1
NIBSC 13/B634 QCRHAVIgMQC2 IgM Anti-HAV Quality Control Serum: Sample2
NIBSC 13/B640 QCRHIV1QC5 - Anti-HIV-1 Quality Control Reagent Sample 5
NIBSC 13/B642 QCRHSV2QC1-Anti-HSV2 Quality Control Serum: Sample 1
NIBSC 13/B644 QCRHIV1QC3-Anti-HIV1:Quality Control Serum:Sample 3
NIBSC 14/100 Human Papillomavirus (HPV) 11 DNA (1st International Standard)
NIBSC 14/104 Human Papillomavirus (HPV) Type 45 DNA (1st International Standard)
NIBSC 14/106 Influenza virus infectious. NYMC BX-51B
NIBSC 14/114 JC Virus (JCV) DNA (1st International Standard)
NIBSC 14/116 Influenza virus infectious NYMC X-179A
NIBSC 14/118 Influenza virus infectious B/Massachusetts/2/2012
NIBSC 14/140 1st International Standard for Anti EV71 Serum Human
NIBSC 14/144 Influenza anti-N2 Neuraminidase serum (A/Victoria/361/2011)
NIBSC 14/146 Influenza Antigen B/Brisbane/60/2008 (NYMCBX-35)(Cell Derived)
NIBSC 14/148 Human Blood Factor IX Concentrate (5th International Standard).
NIBSC 14/156 Meningococcal group X polysaccharide (1st WHO International Standard)
NIBSC 14/160 High titre anti-A in IVIG working reference reagent
NIBSC 14/174 Botulinum Type A Antitoxin, Equine
NIBSC 14/198 HBV,HCV,HIV Multiplex
NIBSC 14/200 Influenza Antigen A/Puerto Rico/8/34 (HINI)
NIBSC 14/206 Influenza virus infectious NYMC X-247
NIBSC 14/210 Biological activities of Rituximab WHO 1st International Standard
NIBSC 14/212 BK Virus (BKV)(1st International Standard)
NIBSC 14/224 Influenza virus infectious. A/Switzerland/9715293/2013
NIBSC 14/226 Influenza Virus Infectious A/South Australia/55/2014
NIBSC 14/228 Influenza Virus Infectious A/Stockholm/6/2014
NIBSC 14/230 Influenza Virus Infectious. A/Norway/466/2014
NIBSC 14/232 Influenza Virus Infectious IVR-175
NIBSC 14/238 Recombinant Tissue factor
NIBSC 14/246 Influenza Virus Infectious NIBRG-301
NIBSC 14/254 Influenza Antigen A/Switzerland/9715293/2013 (NIB88)
NIBSC 14/256 Human Papillomavirus (HPV) Type 6 DNA (1st International Standard)
NIBSC 14/258 Human Papillomavirus (HPV) Type 31 DNA (1st International Standard)
NIBSC 14/260 Human Papillomavirus (HPV) Type 33 DNA (1st International Standard)
NIBSC 14/262 Human Papillomavirus (HPV) Type 52 DNA (1st International Standard)
NIBSC 14/264 Human Papillomavirus (HPV) Type 58 DNA (1st International Standard)
NIBSC 14/274 Influenza Antigen B/Brisbane/9/2014 (Egg Derived)
NIBSC 14/290 4th HCV RNA Genotype Panel for Nucleic Acid Amplification
NIBSC 14/300 High titre anti-A and anti-B in serum (WHO Reference Reagent).
NIBSC 14/306 Influenza Virus Infectious NYMC X-243 40180 E13
NIBSC 14/308 Influenza Virus Infectious IVR-178 40200 E7
NIBSC 14/314 Influenza Virus Infectious NIB-88
NIBSC 14/316 Factor IX activated (FIXa) 2nd WHO International Standard
NIBSC 14/318 Influenza Anti NIBRG-301 (H5) HA Serum (Sheep SH624 and SH625)
NIBSC 14/320 Influenza Virus Infectious B/Utah/9/2014
NIBSC 14/322 Influenza Virus Infectious NIB-91
NIBSC 14/B651 QCRTHBcQC2-Total Anti-HBc Quality Control Serum: Sample2
NIBSC 14/B654 QCRRUBQC1-Anti-Rubella Quality Control Serum: Sample 1
NIBSC 14/B655 QCRVZVQC1-Anti VZV: Quality Control Serum: Sample 1
NIBSC 15/100 Influenza Antigen B/Utah/9/2014 (Cell Derived)
NIBSC 15/102 Activated Blood Coagulation Factor X (FXa), Human
NIBSC 15/104 Influenza Antigen A/South Australia/55/2014 Cell derived
NIBSC 15/106 Ancrod
NIBSC 15/126 Bordetella pertussis toxin (20碌g). (2nd International Standard)
NIBSC 15/130 Clinical Virology Multiplex I: Immunodeficiency panel working reagent for Nucleic Acid Amplification Tests (NAT)
NIBSC 15/134 Influenza Anti-A Switzerland/9715293/2013-Like HA serum
NIBSC 15/136 EBOV RNA NP-VP35-GP in-run control
NIBSC 15/138 EBOV RNA VP40-L in-run control
NIBSC 15/140 Batroxobin
NIBSC 15/148 Influenza Virus Infectious NIB-92
NIBSC 15/154 Influenza Virus Infectious NIB-93
NIBSC 15/158 Influenza Virus Infectious NYMC X-263
NIBSC 15/160 Influenza Virus Infectious NIBRG-306
NIBSC 15/174 Lupus (oligo-specific) anti-dsDNA antibodies WHO Reference Reagent
NIBSC 15/180 Blood Coagulation Factor XI, 2016 Plasma Human (2nd International Standard). Blood Coagulation Factor XII, 2017 Plasma, Human (1st International Standard)
NIBSC 15/182 7th British Working Standard for Blood Coagulation Factors II, IX, X Concentrate
NIBSC 15/184 Influenza Virus Infectious NYMC X-263B
NIBSC 15/188 Influenza Virus Infectious NYMC X-263A
NIBSC 15/194 Influenza Virus Infectious NYMC X-257A
NIBSC 15/196 Influenza Virus Infectious NYMC X-261
NIBSC 15/212 Influenza Virus Infectious NYMC BX-53C
NIBSC 15/220 Anti-EBOV plasma, human (WHO Reference Reagent)
NIBSC 15/222 EBOV RNA NP-VP35-GP (WHO Reference Reagent)
NIBSC 15/224 EBOV RNA VP40-L (WHO Reference Reagent)
NIBSC 15/234 Influenza Virus Infectious B/Texas/2/2013 41340 E7
NIBSC 15/238 Influenza Antigen A/New Caledonia/71/2014 (NYMCX-257A)(Egg derived antigen)
NIBSC 15/240 Erythropoietin Antibody Reference Panel A (1st WHO Reference Panel)
NIBSC 15/242 Erythropoietin Antibody Reference Panel B (1st WHO Reference Panel)
NIBSC 15/248 Influenza Anti A/Anhui/1/2013 (H7) HA Serum (Sheep SH644 & SH645)
NIBSC 15/250 Influenza Virus Infectious NYMC BX-31
NIBSC 15/252 Influenza Virus Infectious A/California/7/2009
NIBSC 15/262 1st International Standard for Ebola virus (EBOV) antibodies Sierra Leone Convalescent Plasma Pool
NIBSC 15/266 HHV-6 Virus 1st WHO International Standard
NIBSC 15/270 CD4 WHO Reference Reagent
NIBSC 15/274 Influenza Virus Infectious NYMC BX-59A
NIBSC 15/276 Hepatitis A Virus VL For Nucleic Acid Amplification Techniques (3rd International Standard)
NIBSC 15/294 Influenza virus infectious NYMC BX-59B
NIBSC 15/296 Sabin monovalent Polio vaccine type 2 (1st International Standard)
NIBSC 15/298 Influenza Virus Infectious B/Brisbane/46/2015
NIBSC 15/300 Influenza Virus Infectious NYMC BX-35 41950 E11
NIBSC 15/304 Parathyroid hormone 1-34, recombinant, human, 2nd WHO International Standard
NIBSC 15/B658 QCRLYMEQC1 - Anti-Lyme QC1
NIBSC 15/B664 QCRMUMPSQC1 - Anti-Mumps Quality Control Reagent Sample 1
NIBSC 15/B667 QCRMEASQC1 Anti-MeaslesQC1
NIBSC 15/B669 QCRHCVQC1-Anti-HCV Quality Control Serum: Sample1
NIBSC 15/B671 QCRHIV1P24QC1-HIV1 p24 Antigen: Quality Control Serum: Sample1
NIBSC 15/B678 QCRPARVB19QC1 Anti-Parvovirus B19QC1
NIBSC 15/B680 QCRHBsQC1- Anti HBs Quality Control Serum: Sample 1
NIBSC 16/104 Norovirus GII Working reagent for Nucleic Acid Amplification Techniques
NIBSC 16/106 Influenza antigen A/California/7/09 (H1N1) (NYMC-X181)
NIBSC 16/108 Influenza Virus Infectious A/PR/8/34
NIBSC 16/110 Zika Virus Working Reagent for Nucleic Acid Amplification Testing (NAT)
NIBSC 16/114 Influenza anti - A/California/7/09 HA serum
NIBSC 16/118 Influenza Antigen B/Brisbane/60/2008 (NYMC BX-35) (Egg Derived)
NIBSC 16/120 WHO 1st International Reference Panel for Genomic JAK2 V617F
NIBSC 16/126 Native Vi polysaccharide (S. Typhi)
NIBSC 16/138 Anti-Typhoid capsular Vi polysaccharide Ig (Human) 1st WHO International Standard
NIBSC 16/152 Meningococcal Serogroup W Polysaccharide
NIBSC 16/158 Influenza Antigen B/Phuket/3073/2013
NIBSC 16/164 Sabin bivalnet Polio vaccines types 1 and 3 (1st International Standard)
NIBSC 16/170 Infliximab(1st International Standard)
NIBSC 16/182 Influenza Anti-A/Hong Kong/4801/2014-like HA Serum
NIBSC 16/190 Mullerian Inhibiting Substance/Anti-Mullerian Hormone, human, recombinant (WHO reference Reagent)
NIBSC 16/192 Influenza Anti - B/Brisbane/60/2008-HA serum
NIBSC 16/194 HIV-1 RNA (4th International Standard)
NIBSC 16/196 Sabin monovalent Polio vaccine type 1(1st International Standard)
NIBSC 16/200 Influenza Virus Infectious NIB-58
NIBSC 16/202 OPV reference mOPV 3
NIBSC 16/204 7th WHO International Standard for Rabies Vaccine
NIBSC 16/206 Meningococcal serogroup Y Polysaccharide
NIBSC 16/208 Influenza Virus Infectious NIB-97 42090 E7
NIBSC 16/210 HIV-1 P24 Antigen (1st international reference panel)
NIBSC 16/236 HIV-2 p26 Antigen (VLP)-HIV-2 A7312 (1st WHO Reference Reagent)
NIBSC 16/238 Influenza Antigen A/Anhui/1/2013 (NIBRG-268) (H7N9)
NIBSC 16/242 Influenza Virus Infectious NIB-98 42110 E7
NIBSC 16/250 1st International Reference Panel for genomic KRAS codons 12 and 13 mutations
NIBSC 16/268 Influenza Virus Infectious X-273
NIBSC 16/270 Influenza Virus Infectious IVR-180 42400 E3/D7/E1
NIBSC 16/274 Influenza Virus Infectious X-275A 42010 E13
NIBSC 16/278 Anti-D Immunglobulin control preparation
NIBSC 16/282 Influenza Virus Infectious X-285 42430 ExE1
NIBSC 16/284 Antiserum to Respiratory Syncytial Virus WHO 1st International Standard
NIBSC 16/286 Influenza Antigen A/Hong Kong/4801/2014 (NYMC X-263B)
NIBSC 16/288 Influenza Virus Infectious X-283A 42420 ExE1
NIBSC 16/290 Influenza Virus Infectious X-285A 42440 ExE1
NIBSC 16/292 Influenza Antigen A/Singapore/GP1908/2015 (IVR-180)
NIBSC 16/296 Human Immunodeficiency Virus type 2 RNA (HIV-2) for Nucleic Acid Amplification Techniques (2nd International Standard)
NIBSC 16/302 Tetanus Toxoid for use in Flocculation Test (3rd International Standard)
NIBSC 16/320 Zika Antibody Working reagent
NIBSC 16/324 Human Adenovirus DNA for nucleic acid amplification techniques (1st WHO international Standard).
NIBSC 16/332 Anti-D Immunoglobulin (Replacement IS)
NIBSC 16/344 WHO Anti-EBOV Convalescent Plasma (International Reference Panel)
NIBSC 16/352 Anti-Asian Lineage Zika Virus Antibody (human) (1st international standard)
NIBSC 16/358 Streptokinase (4th WHO International Standard)
NIBSC 16/360 Influenza Virus Infectious NIB-96 41920 E7
NIBSC 16/362 Influenza Virus Infectious NYMC X-291 42530 E8
NIBSC 16/364 3rd International Standard for Prekallikrein Activator
NIBSC 16/366 Influenza Virus Infectious NYMC X-291A 42540 E8
NIBSC 16/368 HSV-1
NIBSC 16/374 Blood Coagulation Factor V, Plasma, Human. (WHO 2nd International Standard)
NIBSC 16/376 Plasmodium falciparum antigens (1st International Standard)
NIBSC 16/B685 QCRHIV2QC2-Anti HIV2: Quality Control Serum: Sample2
NIBSC 16/B687 QCRHIV1RTDQC1- Anti-HIV1 Quality Control Serum: Sample 1 for Rapid Test Devices
NIBSC 16/B695 QCRTOXOIgMQC1 IgM Anti-Toxoplasma gondii QC1
NIBSC 16/B697 QCREBVVCAQC1
NIBSC 16/B704 QCRTHBcQC1-Total Anti-HBc Quality Control Serum: Sample 1
NIBSC 16/B707 QCREBVNEGQC1
NIBSC 17/100 Prostate Specific Antigen (human)(total: PSA-ACT + free PSA)
NIBSC 17/102 Prostate Specific Antigen (human) (Free), (2nd WHO International Standard)
NIBSC 17/106 Influenza Anti-A/Michigan/45/2015-like HA Serum
NIBSC 17/122 HSV-2
NIBSC 17/124 Influenza Virus Infectious NYMC BX-63 42790 E10/E1
NIBSC 17/126 Influenza Virus Infectious NYMC BX-63A 42780 E10/E1
NIBSC 17/132 Influenza Anti NIBRG-306 (H5) HA Serum (sheep SH672 and SH637)
NIBSC 17/136 Influenza Virus Infectious NIBRG-375 (H7N9)
NIBSC 17/142 Influenza Antigen A/Duck Vietnam/NCVD-1584/2014 (NIBRG-301) (H5N1)
NIBSC 17/154 Influenza Antigen A/Michigan/45/2015 (NYMC X-275)
NIBSC 17/156 Influenza Virus Infectious CNIC-1701 42910 E9
NIBSC 17/160 Sabin Inactivated Polio Vaccine (sIPV) (WHO 1st international Standard)
NIBSC 17/162 Influenza Virus Infectious NYMC X-299 42920 E10
NIBSC 17/164 Influenza Virus Infectious B/Maryland/15/2016 42800 E5
NIBSC 17/182 Influenza Antigen A/Michigan/45/2015 (NYMC X-275)
NIBSC 17/184 Influenza Virus Infectious NIB-103 42610 E7
NIBSC 17/190 Influenza Virus Infectious NYMC X-297 42940 E11
NIBSC 17/194 Influenza Virus Infectious NIB-104
NIBSC 17/204 1st International Standard for Darbepoetin
NIBSC 17/206 14th British Standard for Coagulation Factor VIII Concentrate, Human.
NIBSC 17/210 Influenza Virus Infectious IVR-186 43310 E8
NIBSC 17/212 Anti-HLA Negative Control for FCXM and bead- based assays
NIBSC 17/214 Influenza Anti-B/Phuket/3073/2013 HA serum
NIBSC 17/232 Tumor Necrosis Factor alpha (human rDNA derived)
NIBSC 17/236 Adalimumab (1st WHO International Standard)
NIBSC 17/238 Anti-HLA Positive Control for FCXM and bead-based assays
NIBSC 17/240 5% Immunoglobulin (Negative Control)
NIBSC 17/246 Influenza Antigen A/Singapore/INFIMH-16-0019/2016 (NIB-104)
NIBSC 17/252 Influenza Virus Infectious NYMC BX-69 43220 E13
NIBSC 17/256 Influenza Virus Infectious NYMC BX-69A
NIBSC 17/258 Influenza Virus Infectious B/Alabama/2/2017
NIBSC 17/264 Influenza Virus Infectious A/Michigan/45/2015 43470 E5
NIBSC 17/B710 QCRTOXOQC1 - Anti-Toxoplasma gondii Quality Control Reagent Sample 1
NIBSC 17/B713 QCRSYPHQC2-Anti-Syphilis Quality Control Serum: sample 2
NIBSC 17/B717 QCRHBsGQC1-HBsAg Quality Control Serum: Sample1
NIBSC 17/B718 QCRHBsGQC2-HBsAg Quality Control Serum: Sample2
NIBSC 17/B720 QCRHIV1QC2-AntiHIV 1: Quality Control Serum: Sample 2
NIBSC 17/B723 QCRHEVQC1 - Anti-Hepatitis E Quality Control Sample 1
NIBSC 17/B725 QCRTHAVQC1-Total Anti-HAV Quality Control Serum: Sample1
NIBSC 17/B728 QCRHEVIgMQC1 - IgM Anti-Hepatitis E Quality Control Sample 1
NIBSC 18/100 Influenza Antigen B/Maryland/15/2016
NIBSC 18/104 Influenza Antigen B/Maryland/15/2016 (NYMC BX-69A)
NIBSC 18/108 Influenza anti-A/Singapore/INFIMH-16-0019/2016- like HA serum
NIBSC 18/110 Influenza Antigen A/Singapore/INFIMH-16-0019/2016 (IVR-186)
NIBSC 18/112 Influenza anti-A/Guangdong-17SF003/2016 (H7) (NIBRG-375) HA Serum
NIBSC 18/116 WHO International Standard Enterovirus 71 (EV71) Inactivated vaccine (Geno Group C4)
NIBSC 18/118 1st International Standard for HCT 15 Cancer Genome
NIBSC 18/120 WHO Reference Reagent Enterovirus 71 (EV71) Inactivated Vaccine (Geno Group C4)
NIBSC 18/130 1st International Standard for MOLT-4 Cancer Genome
NIBSC 18/134 Influenza Virus Infectious NIBRG-301 (H5N1)
NIBSC 18/138 Influenza Virus Infectious NYMC X-307A
NIBSC 18/140 Influenza Virus Infectious NYMC X-307
NIBSC 18/144 WHO 1st Reference Reagent for Lentiviral Vector Integration Site Analysis
NIBSC 18/146 Pertussis antiserum (human) panel
NIBSC 18/154 Bordetella pertussis, pertactin, PRN
NIBSC 18/156 WHO Reference Reagent Enterovirus 71 (EV71) Inactivated Vaccine (Geno Group B4)
NIBSC 18/160 Influenza Virus Infectious NYMC X-311
NIBSC 18/164 1st International Standard for ATDB102 Genome
NIBSC 18/166 Influenza Virus Infectious NIB-112 43990 E6
NIBSC 18/168 Influenza Virus Infectious A/Switzerland/8060/2017
NIBSC 18/170 Influenza anti-B/Colorado/06/2017-like HA serum
NIBSC 18/174 Influenza Virus Infectious A/Brisbane/1/2018
NIBSC 18/184 Hepatitis C virus RNA for nucleic acid amplification techniques (6th WHO International Standard)
NIBSC 18/188 Influenza Antigen A / Switzerland / 8060 / 2017 (NIB-112)
NIBSC 18/190 Influenza Antigen A / Brisbane/ 01/2018 (NYMC X-311)
NIBSC 18/192 Influenza Anti-A/Switzerland/8060/2017-like (H3N2) HA Serum
NIBSC 18/194 Influenza Virus Infectious NYMC X-275 (Influenza Reagent)
NIBSC 18/196 Influenza Antigen A/Guangdong/17SF003/2016. NIBRG-375 (H7N9)
NIBSC 18/206 West Nile Virus - International Standard
NIBSC 18/208 West Nile Virus International Standard
NIBSC 18/210 Bevacizumab (1st WHO International Standard)
NIBSC 18/220 Anti-HPA 15b minimum potency reagent (WHO Reference Reagent)
NIBSC 18/226 Influenza Virus Infectious IVR-190 44250 E12
NIBSC 18/230 Influenza Virus Infectious B/Colorado/06/2017 43460 E7
NIBSC 18/234 Influenza Virus Infectious NIB116-B 44230 E5
NIBSC 18/236 Influenza Virus Infectious A/Brisbane/02/2018
NIBSC 18/238 Influenza Antigen A/Brisbane/02/2018 (IVR-190) (H1N1)
NIBSC 18/240 Influenza Virus Infectious NYMC X-327 44280 E17
NIBSC 18/242 Influenza Virus Infectious A/Kansas/14/2017 43880 E8
NIBSC 18/244 Human Chorionic Gonadotrpin (hCG) (6th International Standard)
NIBSC 18/B731 Anti CMV QC1 QCRCMVQC1
NIBSC 18/B732 QCRNEGQC1-Negative Quality Control Serum: Sample1
NIBSC 18/B733 QCREBVIgMQC1
NIBSC 18/B742 QCRLYMEIgMQC1 IgM Anti-Lyme QC1
NIBSC 19/102 Influenza anti-A/Brisbane/02/2018-like (H1N1) HA Serum (Sheep 698, 699, 700, 701)
NIBSC 19/104 Influenza antigen A/Kansas/14/2017 (NYMC X-327) (H3N2)
NIBSC 19/106 Influenza Virus Infectious IVR-195 44300 E9
NIBSC 19/108 Trastuzumab (1st WHO international Standard)
NIBSC 19/112 Influenza Virus Infectious NIB-110
NIBSC 19/120 Influenza Virus Infectious X-327 A 44310 E18
NIBSC 19/146 Influenza Virus Infectious CNIC-1903
NIBSC 19/148 Influenza Virus Infectious CNIC-1902 44320 E10
NIBSC 19/152 Influenza anti-A/Kansas/14/2017 - Like (H3N2) HA Serum
NIBSC 19/154 Influenza Antigen A/Kansas/ 12/2017 (IVR-195) (H3N2)
NIBSC 19/156 Panel of recombinant antibody controls for Cytokine Release Assays
NIBSC 19/166 Insulin-like Growth Factor I, for Immunoassay (2nd WHO international Standard)
NIBSC 19/172 Influenza Virus Infectious BVR-11
NIBSC 19/174 Influenza Virus Infectious IVR-197 (H3N2) 44850 E14
NIBSC 19/176 Influenza Virus Infectious B/Victoria/705/2018
NIBSC 19/178 1st WHO International Standard for Anti-MERS-CoV Immunoglobulin G (Human)
NIBSC 19/180 Non WHO Reference material Working reagent for Anti-MERS-CoV Antibody
NIBSC 19/188 3rd International Standard Thrombin
NIBSC 19/192 Influenza Virus Infectious IVR-202 (H3N2) 44880 E10
NIBSC 19/194 Influenza Virus Infectious B/Brisbane/35/2018
NIBSC 19/196 Influenza Virus Infectious B/Phuket/3073/2013 44860 E7
NIBSC 19/204 Influenza Antigen A/Newcastle/82/2018 (H3N2) (cell derived)
NIBSC 19/206 Influenza Virus Infectious X-181 45030 E8
NIBSC 19/208 Influenza Antigen B/Victoria/705/2018 (BVR-11) (B Victoria Lineage)
NIBSC 19/210 Influenza Antigen B/Darwin/7/2019 (B Victoria Lineage) (Cell Derived)
NIBSC 19/212 Influenza Antigen A/South Australia/34/2019 (IVR-197) (H3N2)
NIBSC 19/216 Influenza Anti-A/South Australia/34/2019-Like (H3N2) HA Serum (Sheep 712, 713, 714, 715, 716)
NIBSC 19/224 Collection of WHO International Standards for Human Papillomavirus (HPV) DNA genotypes HPV16, HPV18, HPV6, HPV11
NIBSC 19/226 Collection of WHO International Standards for Human Papillomavirus (HPV) DNA genotypes HPV31, HPV33, HPV45, HPV52, HPV58
NIBSC 19/228 Influenza Virus Infectious A/South Australia/34/2019
NIBSC 19/230 Influenza Virus Infectious A/Christchurch/516/2019 H3N2 45010 E4
NIBSC 19/236 Diphtheria Antitoxin Equine (DI)
NIBSC 19/238 Influenza Antigen B/Washington/02/2019 9B Victoria Lineage)
NIBSC 19/240 British Working Standard for Anti-HCV
NIBSC 19/242 British Working Standard for Anti HCV 1 in 8 Dilution
NIBSC 19/256 Influenza Virus Infectious BX-85C 45230 E13
NIBSC 19/258 Influenza Virus Infectious CNIC-1906 44910 E3+3/E9/E1
NIBSC 19/262 Influenza Virus Infectious CNIC-1909 (H1N1) 45290 E2/E8/E1
NIBSC 19/276 Influenza Virus Infectious NIB-121 (H3N2) 45180 E7/E1/E5
NIBSC 19/292 Influenza Virus Infectious A/HongKong/2671/2019 (H3N2) 45040 E7/E1
NIBSC 19/294 Influenza Virus Infectious A/Guandong-Maonan/SWL1536/2019 (H1N1) 44760 E3/E1
NIBSC 19/304 Research reagent for SARS-CoV-2 RNA
NIBSC 19/306 Influenza Antigen A/Victoria/2454/2019 (IVR-207) (H1N1)
NIBSC 19/308 Influenza Antigen B/Singapore/INFTT-16-0610/2016 (B Yamagata lineage) (cell derived)
NIBSC 19/312 Influenza Antigen A/Guangdong-Maonan/SWL1536/2019 (CNIC-1909) (H1N1)
NIBSC 19/314 Influenza Anti-A/ Guangdong-Maonan/SWL 1536/2019-like (H1N1) HA Serum (Sheep 723, 724, 725, 726, 727, 728)
NIBSC 19/316 Influenza anti-A/hongKong/2671/2019-like (H3N2) HA Serum (Sheep 729, 730, 731, 732, 733, 734)
NIBSC 19/318 Influenza anti-B/Washington/02/2019-like (B Victoria lineage) HA Serum (Sheep 737, 738, 739, 740, 741, 742)
NIBSC 19/320 Influenza anti-N2 Neuraminidase Serum (A/South Australia/34/2019) (Sheep 735, 736)
NIBSC 19/322 Influenza anti-B/Phuket/3073/2013-like (B Yamagata Lineage) HA serum (Sheep 743, 744, 745, 746, 747, 748)
NIBSC 19/B747 QCRHIV2QC4 - Anti HIV2 Quality Control Serum Sample 4
NIBSC 19/B751 QCREBNAQC1
NIBSC 19/B752 Ferritin Quality Control Sample
NIBSC 19/B753 QCREBVEAQC1
NIBSC 19/B754 Anti-Rubella QC2
NIBSC 20/102 Influenza Virus Infectious IVR-207 (H1N1) 45370 E4/E6/E1
NIBSC 20/104 Influenza Virus Infectious IVR-208 (H3N2) 45330 E7/E10/E1
NIBSC 20/106 Influenza Virus Infectious A/Victoria/2454/2019 (H1N1) 45360 E4/E1
NIBSC 20/108 Influenza Antigen A/HongKong/2671/2019 (NIB-121)(H3N2)
NIBSC 20/110 SARS-CoV-2 (NAT)
NIBSC 20/112 IVIG + Anti-D (13/148)x2 Negative Control IVIG (12/300) x2
NIBSC 20/130 Research Reagent for Anti-SARS-CoV-2 Ab
NIBSC 20/132 Influenza Antigen A/HongKong/2671/2019 (IVR-208) (H3N2)
NIBSC 20/134 Influenza Virus Infectious BX-57 45430 E4/E10/E1
NIBSC 20/136 First WHO International Standard Anti-SARS-CoV-2 Immunoglobulin (Human)
NIBSC 20/138 Working Reagent for SARS-CoV-2 RNA
NIBSC 20/146 First WHO International Standard for SARS-CoV-2 RNA
NIBSC 20/162 NIBSC Anti-SARS-CoV-2 Antibody Diagnostic Calibrant
NIBSC 20/164 Influenza Virus Infectious BX-87C (B/VIC) 45460 E3/E10/E1
NIBSC 20/170 NHS winter Multiplex Working Reagent for Nucleic acid amplification testing (NAT)
NIBSC 20/180 Influenza A (H1N1) Panel
NIBSC 20/182 Influenza A (H3N2) Panel
NIBSC 20/184 Influenza B Panel
NIBSC 20/186 RSV A Panel
NIBSC 20/188 RSV B Panel
NIBSC 20/190 SARS-CoV-2 Panel
NIBSC 20/212 Influenza virus infectious IVR-215 (H1N1) 45620 E4/D7/E1
NIBSC 20/214 Influenza Virus Infectious IVR-216 (H1N1) 45630 E4/D6/E1
NIBSC 20/216 Influenza virus Infectious A/Victoria/2570/2019 (H1N1) 45380 E5
NIBSC 20/220 Influenza Virus Infectious IVR-217 (H1N1) 45640 E4/D6/E1
NIBSC 20/232 Influenza Antigen A/Victoria/2570/2019 (IVR-215) (H1N1)
NIBSC 20/234 Influenza Anti-A/Victoria/2570/2019-like (H1N1) HA Serum (Sheep 749, 750, 751, 752, 753, 754)
NIBSC 20/236 Influenza Virus Infectious X-349 (H1N1) E3/E9/E1 45720
NIBSC 20/238 Influenza Virus Infectious X-349A (H1N1) E3/E11/E1 45730
NIBSC 20/242 Influenza Virus Infectious B/Washington/02/2019 E4 44600
NIBSC 20/264 Influenza Virus Infectious X-341 + 1P (H3N2)
NIBSC 20/266 Nucleic Acid Amplification Technique (NAT) Panel for SARS-CoV-2
NIBSC 20/268 1st International Reference Panel for Anti-SARS-CoV-2 Immunoglobulin
NIBSC 20/274 Influenza Virus Infectious A/Tasmania/503/2020 (H3N2)
NIBSC 20/296 Influenza Virus Infectious X-347A (H3N2)
NIBSC 20/310 Influenza Virus Infectious A/Cambodia/E0826360/2020 (H3N2)
NIBSC 20/B758 QCRHIV1p24QC2-HIV1 p24 Antigen: Quality Control Serum: Sample2
NIBSC 20/B764 QCRSARSCoV2QC1
NIBSC 20/B767 QCRSYPHQC1-Anti-Syphilis Quality Control Serum: Sample 1
NIBSC 20/B770 Anti-SARS-CoV-2 Verification Panel for Serology Assays
NIBSC 20/B774 QCRPARVB19IgMQC1 - IgM Anti-Parvovirus B19 Quality Control Reagent 1
NIBSC 234 IPV ELISA MAbs Type 1, 2 and 3 (Type 1; No: 234)
NIBSC 2BADS Anti-Brucella Abortus Serum, Bovine (International Standard)
NIBSC 2CPBETAAT Clostridium Perfringens Beta Antitoxin (2nd International Standard)
NIBSC 2CPEPAT Clostridium Perfringens Epsilon Antitoxin (2nd International Standard)
NIBSC 520 IPV ELISA MAbs Type 1, 2 and 3 (Type 3; No: 520)
NIBSC 59/015 Gas Gangrene (Cl. Perfringens(Cl. Welchii) Type A), Equine
NIBSC 59/016 Corticotrophin (ACTH), Porcine (3rd International Standard)
NIBSC 59/021 Botulinum Antitoxin Equine Type A
NIBSC 60/001 Botulinum Antitoxin Equine Type B
NIBSC 60/013 Tetanus Antitoxin, Equine, for Bioassay
NIBSC 61/001 Botulinum Antitoxin Equine Type D (1st International Standard)
NIBSC 62/014 Lysine Vasopressin, Porcine
NIBSC 63/005 Gas Gangrene Antitoxin (Cl. Histolyticum), Equine
NIBSC 64/002 Rheumatoid Arthritis Serum
NIBSC 64/014 Gas Gangrene Antitoxin (Cl. Septicum), Equine
NIBSC 64/024 Gas Gangrene Antitoxin (Cl. Oedematiens), Equine
NIBSC 65/093 Anti-Thyroglobulin Serum, Human (WHO Reference reagent)
NIBSC 65/119 Renin, Porcine
NIBSC 65/122 Long-acting Thyroid Stimulator, Human
NIBSC 66/021 Tetanus Antitoxin, Equine, for Flocculation Test
NIBSC 66/138 Gastrin II, Porcine
NIBSC 66/153 Diphtheria Antitoxin, Equine
NIBSC 66/233 Anti-Nuclear Factor Serum (Homogenous) Human
NIBSC 67/037 Immunoglobulin D (IgD) Serum, Human
NIBSC 67/086 Immunoglobulins G, A, M Serum Human (International Standard)
NIBSC 67/099 Immunoglobulins G, A & M Serum Human
NIBSC 67/182 Anti-Rubella Serum, Human
NIBSC 67/183 Primary Biliary Cirrhosis Serum, Human
NIBSC 68/340 Anti-Nucleolar Factor Plasma, Human
NIBSC 68/356 Renin, Human (International Standard)
NIBSC 69/065 Autoimmune Antibody to Human Spermatazoa
NIBSC 69/194 Glucagon, Porcine (First International Standard)
NIBSC 70/302 Angiotensin II (25碌g)
NIBSC 71/281 Anti-Malaria Plasma P Vivax
NIBSC 71/326 Anti-Malaria Plasma Vivax Ng2
NIBSC 72/092 Anti-malaria Plasma: Plasmodium falciparum (Ghana)
NIBSC 72/096 Anti-Malaria Serum (P.Malariae)
NIBSC 72/341 Anti-Malaria Plasma P Falciparum
NIBSC 72/345 Anti-Malaria Plasma P Falciparum
NIBSC 72/348 Anti-Malaria Plasma P Vivax
NIBSC 73/517 Anti-D (Rho) Antibodies, Human
NIBSC 73/545 Placental Lactogen, Human (International Reference Preparation)
NIBSC 73/554 Cholera Vaccine (Inaba)
NIBSC 73/556 Cholera Vaccine (Ogawa)
NIBSC 73/601 Carcinoembryonic Antigen (CEA), Human (1st International Reference Preparation)
NIBSC 74/520 Serum Proteins (Other than Immunoglobulins) Human
NIBSC 74/581 Ancrod (1st International Reference Preparation)
NIBSC 74/586 Corticotrophin (ACTH), Porcine (International Working Standard)
NIBSC 75/506 Cocksfoot Pollen Extract
NIBSC 75/533 Chorionic Gonadotrophin, Human, for Radioiodination
NIBSC 75/535 Chorionic Gonadotrophin beta, Human, for Radioiodination
NIBSC 75/551 Chorionic Gonadotrophin beta Subunit, Human (International Reference Preparation)
NIBSC 75/569 Chorionic Gonadotrophin alpha subunit, Human (International Reference Preparation)
NIBSC 75/595 Blood Coagulation Factor Xa, Bovine
NIBSC 76/508 Chorionic Gonadotrophin alpha Subunit, Human, for Radioiodination
NIBSC 76/515 Mannan (Candida Albicans) Purified
NIBSC 76/522 Opacity 5IRP WHO International Standard
NIBSC 76/525 Anti-Birch Pollen Serum, Human
NIBSC 76/547 Influenza anti A/Victoria/3/75 Serum(goat)
NIBSC 76/575 Oxytocin(4th International Standard)
NIBSC 76/589 Tetanus Antitoxin, Human, Immunoglobulin
NIBSC 77/503 Anti-Cocksfoot Serum, Human
NIBSC 77/512 Lysine Vasopressin(1st International Standard)
NIBSC 77/531 Influenza anti A/New Jersey/8/76(H1N1) Serum
NIBSC 77/568 Influenza anti B/Hong Kong/8/73 Serum
NIBSC 77/584 Anti-D Pteronyssinus Serum, Human
NIBSC 77/600 Mannan (Candida Albicans) Purified
NIBSC 77/616 Twelve Grass Pollen Extract
NIBSC 77/643 Secretin
NIBSC 77/662 Acarus Siro Extract
NIBSC 77/664 Glycyphagus destructor Extract
NIBSC 78/517 Tyrophagus Putrescentiae Extract
NIBSC 78/543 Kininogenase (Porcine, Pancreatic) (Formerly 1st International Standard)
NIBSC 78/545 Anti-Aspergillus fumigatus Serum, Human
NIBSC 78/554 Luteinizing Hormone, Pituitary, alpha subunit (International Standard)
NIBSC 78/556 Luteinizing Hormone, Pituitary, beta subunit (International standard)
NIBSC 78/560 Influenza Antigen A/Texas/1/77
NIBSC 78/569 Influenza anti A/Texas/1/77 Serum
NIBSC 78/575 Aspergillus Fumigatus Extract
NIBSC 78/582 Tyrophagus Longior Extract
NIBSC 78/628 Bee Venom
NIBSC 79/500 Parathyroid Hormone, HumanRef. Preparation)
NIBSC 79/516 Influenza anti A/Brazil/11/78 Serum (goat)
NIBSC 79/552 Influenza Antigen A/USSR/92/77
NIBSC 79/558 Influenza Antigen A/USSR/92/77
NIBSC 79/560 Influenza Antigen A/Brazil/11/78
NIBSC 79/568 Influenza Antigen B/Hong Kong/8/73
NIBSC 79/572 Prekallikrein Activator (PKA), Human
NIBSC 80/505 Growth Hormone, Human, Pituitary. WHO International Standard
NIBSC 80/517 Influenza Antigen A/Bangkok/1/79
NIBSC 80/519 Influenza Antigen B/Singapore/222/79
NIBSC 80/523 Influenza anti B/Singapore/222/79 Serum
NIBSC 80/525 Influenza anti A/Bangkok/1/79 Serum
NIBSC 80/590 Tetracosactide. International Ref. Preparation
NIBSC 81/535 Luteinizing Hormone, Human, Pituitary (3rd International Standard)
NIBSC 81/565 Thyroid Stimulating Hormone, Human. WHO International Standard
NIBSC 82/508 Parathyroid Hormone, Human-Type, Synthetic (1-34) fragment
NIBSC 82/512 Parathyroid Hormone, Bovine-Type, Synthetic (1-34) fragment
NIBSC 82/518 Dermatophagoides Pteronyssinus Extract. WHO International Standard
NIBSC 82/520 Timothy Pollen Extract. WHO International Standard
NIBSC 82/585 Anti Poliovirus serum types 1,2 and 3 (3rd International Standard)
NIBSC 82/587 Interferon Gamma (Human, Leukocyte derived)
NIBSC 82/632 Parathyroid Hormone, Bovine. WHO International Standard
NIBSC 82/652 Human Serum Vitamin B12, Pernicous anaemia
NIBSC 83/501 Beta Thromboglobulin, Purified Human. WHO International Standard
NIBSC 83/505 Platelet Factor 4 Human, Purified. WHO International Standard
NIBSC 83/511 Insulin, Bovine. WHO International Standard
NIBSC 83/514 Interferon alpha-1D, (Human rDNA derived) WHO International Standard
NIBSC 83/515 Insulin, Porcine. WHO International Standard
NIBSC 83/537 Influenza Antigen A/Philippines/2/82
NIBSC 83/545 Influenza anti A/Philippine/2/82 Serum
NIBSC 83/550 Influenza Antigen A/Brazil/11/78
NIBSC 83/573 Prolactin, Human (4th WHO International Standard.)
NIBSC 83/575 Follicle Stimulating Hormone, Pituitary. WHO International Standard
NIBSC 84/514 Proinsulin, Bovine. International Ref. Preparation
NIBSC 84/522 Birch Pollen Extract. WHO International Standard
NIBSC 84/528 Proinsulin, Porcine. International Ref. Reagent
NIBSC 84/538 Influenza Antigen A/Chile/1/83
NIBSC 84/542 Influenza Antigen B/Norway/1/84
NIBSC 84/581 Short Ragweed Pollen Extract. WHO International Standard
NIBSC 84/614 Calcitonin, ASU 1-7 Eel Calcitonin Analogue (Elcatonin) WHO International Standard
NIBSC 84/628 Anti-c Serum, Human
NIBSC 84/636 Influenza anti B/USSR/100/83 Serum
NIBSC 84/640 Influenza anti A/Chile/1/8 Serum
NIBSC 84/677 Influenza anti A/equine/Miami/63 (H3N8) Serum(goat)
NIBSC 84/685 Dog (Canis Familiaris) Hair Dander Extract. WHO International Standard
NIBSC 85/506 C-Reactive Protein, Human. WHO International Standard
NIBSC 85/516 Influenza anti A/Equine/Kentucky/1/81 HA Serum
NIBSC 85/520 Influenza Antigen A/Equine/Kentucky/1/81
NIBSC 85/522 Thyroid Stimulating Hormone beta subunit
NIBSC 85/551 Anti-Rye Grass Serum, Human
NIBSC 85/616 Haemoglobin F Lysate, Raised. WHO Reference Reagent
NIBSC 85/669 Atrial Natriuretic Factor, Human. WHO International Standard
NIBSC 86/500 Interleukin- 2 (Human, rDNA derived)(2nd International Standard)
NIBSC 86/536 Angiotensin I Human Type Synthetic
NIBSC 86/538 Angiotensin II (2.5碌g)
NIBSC 86/552 Interleukin-1 Beta (Human, rDNA derived)
NIBSC 86/576 Influenza Antigen A/Mississippi/1/85
NIBSC 86/590 Influenza anti A/Mississippi/1/85 Serum
NIBSC 86/592 Influenza anti B/Ann Arbor/1/86/HA Serum
NIBSC 86/630 Influenza Antigen B/Ann Arbor/ 1/86
NIBSC 86/632 Interleukin-1 alpha (Human rDNA derived) WHO International Standard
NIBSC 86/678 Interleukin-1 alpha (Human, rDNA derived)
NIBSC 86/680 Interleukin-1 beta (Human, rDNA derived) WHO International Standard
NIBSC 86/690 Inhibin, Porcine WHO International Standard
NIBSC 87/510 Influenza Antigen A/Equine/Miami/63
NIBSC 87/578 Influenza anti A/Leningrad/360/86 Serum
NIBSC 87/584 Influenza Antigen A/Leningrad/360/86
NIBSC 87/586 Interferon Gamma (Human, rDNA derived)
NIBSC 87/640 Tumour Necrosis Factor beta (Human, rDNA derived) WHO Reference Reagent
NIBSC 87/654 Anti-Ferritin Monoclonal Antibody (1)
NIBSC 87/662 Anti-Ferritin Monoclonal Antibody (2)
NIBSC 87/714 Influenza Antigen A/Sichuan/2/87
NIBSC 87/774 Influenza Antigen B/Victoria/2/87
NIBSC 88/522 Bordetella pertussis (Whole cell vaccine) 3BRP
NIBSC 88/532 Tumour Necrosis Factor alpha (Mouse, rDNA derived)
NIBSC 88/554 Influenza Antigen B/Beijing/1/87
NIBSC 88/556 Calcitonin, Eel WHO International Standard
NIBSC 88/638 Thyroxine-binding globulin. WHO International Standard
NIBSC 88/646 Granulocyte Macrophage Colony Stimulating Factor (Human, rDNA derived) WHO International Standard
NIBSC 88/654 Influenza Antigen A/England/427/88
NIBSC 88/656 Interleukin-4 (Human, rDNA derived) WHO International Standard
NIBSC 88/672 Influenza anti A/Sichuan/2/87 Serum
NIBSC 88/678 Influenza anti B/Beijing/1/87 Serum
NIBSC 88/846 Influenza anti A/England/427/88 Serum
NIBSC 89/512 Macrophage Colony Stimulating Factor (CSF-1) (Human rDNA derived) WHO International Standard
NIBSC 89/514 Transforming Growth Factor beta-1 (Human, rDNA derived)
NIBSC 89/516 Transforming Growth Factor beta-1 (Bovine)
NIBSC 89/518 Transforming Growth Factor beta-2 (Bovine)
NIBSC 89/520 Interleukin-8 (Human, rDNA derived) WHO International Standard
NIBSC 89/530 Anti-Bordetella pertussis serum (Human)
NIBSC 89/544 Renin, Human, rec DNA
NIBSC 89/548 Interleukin-6 (Human, rDNA derived) WHO International Standard
NIBSC 89/568 Influenza Antigen A/OMS/5389/88
NIBSC 89/594 Bordetella pertussis (W28) LPS 2ug
NIBSC 89/596 Bordetella pertussis anti-agglutinogen 1(rabbit)
NIBSC 89/598 Bordetella pertussis anti-agglutinogen 2 (rabbit)
NIBSC 89/600 Bordetella pertussis anti-agglutinogen 3 (rabbit)
NIBSC 89/620 Calcitonin, Human. WHO International Standard
NIBSC 89/666 Haemoglobin A2 Lysate, Raised. WHO Reference Reagent
NIBSC 89/670 Bordetella pertussis (W28) LPS25ug
NIBSC 90/500 Influenza Antigen A/Shanghai/16/89
NIBSC 90/502 Influenza Antigen A/Guizhou/54/89
NIBSC 90/504 Influenza anti A/Guangdong/39/89 Serum
NIBSC 90/520 Bordetella pertussis, filamentous haemagglutinin (FHA)
NIBSC 90/530 Interleukin-7 (Human, rDNA derived) WHO Reference Reagent
NIBSC 90/534 Mumps Vaccine (Live) WHO Reference Reagent
NIBSC 90/586 Interleukin-5 (Human, rDNA derived) WHO Reference Reagent
NIBSC 90/636 HIV-1 P24 Antigen WHO International Standard
NIBSC 90/690 Anti-Varicella-Zoster Antibody
NIBSC 90/696 Transforming Growth Factor beta-2, Human, rec DNA
NIBSC 90/712 Basic Fibroblast Growth Factor (Human, rDNA derived) WHO International Standard
NIBSC 90/784 Influenza Virus infectious NIB-26 (H3N2)
NIBSC 91/510 Interleukin-3 (Human, rDNA derived) WHO International Standard
NIBSC 91/530 Epidermal Growth Factor (Human, rDNA derived) WHO International Standard
NIBSC 91/550 Epidermal Growth Factor (1-52) (Human, rDNA derived) WHO Reference Reagent
NIBSC 91/554 Insulin-like growth Factor 1 WHO International Standard
NIBSC 91/612 Influenza anti A/Taiwan/1/86 Serum
NIBSC 91/624 Recombinant Human Inhibin
NIBSC 91/626 Activin A, Human, Recombinant. WHO Reference Reagent
NIBSC 91/656 Interleukin-4 (Mouse, rDNA derived)
NIBSC 91/658 Granulocyte Macrophage Colony Stimulating Factor (Mouse rDNA derived)
NIBSC 91/662 Interleukin-3 (Mouse, rDNA derived)
NIBSC 91/670 Influenza Virus infectious NIB-27 (H1N1)
NIBSC 91/678 Interleukin-9 (Human,rDNA derived) WHO Reference Reagent
NIBSC 91/682 Stem Cell Factor (Human rDNA derived) WHO Reference Reagent
NIBSC 91/688 Rubella Vaccine (Live) 1st International Reference Reagent
NIBSC 92/510 Follicle Stimulating Hormone, Human, recombinant. (WHO International Standard)
NIBSC 92/512 Follicle Stimulating Hormone, urofollitropin Human Urinary WHO International Standard
NIBSC 92/518 Macrophage Inflammatory Protein-1 alpha (Human, rDNA derived)
NIBSC 92/520 Rantes (Human, rDNA derived)
NIBSC 92/530 Influenza Antigen A/Texas/36/91
NIBSC 92/582 Influenza anti B/Yamagata/16/88 Serum
NIBSC 92/628 Influenza Antigen B/Yamagata/16/88
NIBSC 92/632 Influenza anti A/Beijing/352/89 (H3N2) Serum
NIBSC 92/644 Interleukin-1 Receptor Antagonist (IL-1ra) (Human, rDNA derived)
NIBSC 92/648 Measles Vaccine (Live) 2nd International Reference Reagent
NIBSC 92/654 Plasminogen Activator Inhibitor-1 (PAI-1), plasma Human WHO International Standard
NIBSC 92/658 Papain preparation for use with Anti-D preparation 91/562
NIBSC 92/680 Serum amyloid A protein. WHO International Standard
NIBSC 92/734 Influenza Virus infectious A/Beijing/32/92 (H3N2)
NIBSC 92/738 Influenza Virus infectious A/Shanghai/24/90
NIBSC 92/788 Interleukin-11 (Human, rDNA derived) WHO Reference Reagent
NIBSC 92/794 Monocyte Chemoattractant Protein-1 (Human,rDNA derived)
NIBSC 93/500 Influenza Antigen A/Beijing/32/92
NIBSC 93/516 Influenza Antigen A/Shanghai/24/90
NIBSC 93/518 Influenza anti A/Beijing/32/92 (H3N2) Serum
NIBSC 93/522 Influenza anti A/Shanghai/24/90 (H3N2) Serum
NIBSC 93/556 Nerve Growth Factor (Human, rDNA derived) WHO Reference Reagent
NIBSC 93/560 Insulin-like growth Factor Binding Protein-3
NIBSC 93/562 Leukaemia Inhibitory Factor (Human, rDNA derived) WHO Reference Reagent
NIBSC 93/564 Oncostatin M (Human, rDNA derived) WHO Reference Reagent
NIBSC 93/566 Interleukin-2 (Mouse, rDNA derived)
NIBSC 93/568 Influenza Virus infectious A/Beijing/359/89 (H3N2)
NIBSC 93/574 Bone morphogenetic Protein-2 (Human, rDNA derived) WHO Reference Reagent
NIBSC 93/668 Interleukin-1 beta (Mouse, rDNA derived)
NIBSC 93/672 Interleukin-1 alpha (Mouse, rDNA derived)
NIBSC 93/692 Influenza Virus infectious B/Panama/45/90
NIBSC 93/722 Interleukin-10 (Human rDNA derived) WHO Reference Reagent
NIBSC 93/730 Interleukin-6 (Mouse, rDNA derived)
NIBSC 93/740 Interleukin-7 (Mouse, rDNA derived)
NIBSC 93/816 Influenza Virus infectious A/Harbin/15/92 (H3N2)
NIBSC 94/500 Influenza Antigen B/Panama/45/90
NIBSC 94/504 Influenza anti A/Shanghai/9/93 Serum
NIBSC 94/516 Influenza Antigen A/Shangdong/9/93
NIBSC 94/520 Influenza anti B/Panama/45/90 Serum
NIBSC 94/532 Pertussis Vaccine (Whole Cell) WHO International Standard
NIBSC 94/572 Ferritin, Human, recombinant. WHO International Standard
NIBSC 94/622 Interleukin-13 (Human, rDNA derived) WHO Reference Reagent
NIBSC 94/674 Thyroid Stimulating Hormone, Human recombinant WHO Reference Reagent
NIBSC 94/684 Ciliary Neurotrophic Factor (Human, rDNA derived) WHO Reference Reagent
NIBSC 94/718 Staphylokinase, rec (STAR)
NIBSC 94/728 Platelet-derived Growth Factor-BB (Human, rDNA derived) WHO International Standard
NIBSC 94/730 Tissue Plasminogen Activator (tPA) Antigen in Plasma WHO International Standard
NIBSC 94/754 Interferon Omega (Human, rDNA derived) WHO International Standard
NIBSC 94/762 Influenza Virus infectious RESVIR-8 (H3N2)
NIBSC 94/766 Influenza Virus infectious NIB-34 (H3N2)
NIBSC 94/784 Interferon alpha (Human, leukocyte derived)WHO International Standard
NIBSC 94/786 Interferon alpha Concensus Sequence (Human rDNA derived) WHO International Standard
NIBSC 94/790 MAPREC analysis of Poliovirus type 3 (Sabin). Synthetic DNA 100% 472-C WHO International Standard
NIBSC 95/510 Influenza Antigen A/Texas/36/91
NIBSC 95/516 Influenza Antigen A/Johannesburg/33/94
NIBSC 95/522 Anti-HBc (Anti-hepatitis B core antigen) WHO International Standard
NIBSC 95/524 Influenza anti A/Johannesburg/33/94 Serum
NIBSC 95/528 Folate, Whole Blood Haemolysate WHO International Standard
NIBSC 95/542 MAPREC analysis of Poliovirus type 3 (Sabin) Synthetic DNA 0.9% 472-C WHO International Standard
NIBSC 95/544 Interleukin-12 (Human, rDNA derived) WHO Reference Reagent
NIBSC 95/554 Interleukin-15 (Human, rDNA derived) WHO Reference Reagent
NIBSC 95/564 Single Chain Urinary-Type Plasminogen Activator (SCuPA), (Non-Glyc)
NIBSC 95/566 Interferon alpha-2b (Human, rDNA derived) WHO International Standard
NIBSC 95/568 Interferon Alpha n1 (Human lymphoblastoid cell derived) WHO International Standard
NIBSC 95/572 Interferon alpha-1/8 (Human, rDNA derived) WHO International Standard
NIBSC 95/574 Interferon Alpha n3 (Human, leukocyte derived) WHO International Standard
NIBSC 95/580 Interferon alpha-2c (Human, rDNA derived) WHO International Standard
NIBSC 95/646 Parathyroid Hormone 1-84, human, recombinant (1st International Standard)
NIBSC 95/650 Interferon alpha-2a (Human, rDNA derived) WHO International Standard
NIBSC 95/668 Single Chain Urinary-Type Plasminogen Activator (SCuPA), (Glyc)
NIBSC 95/674 Anti-Meningococcal Serogroup A mAb
NIBSC 95/678 Anti-Meningococcal Serogroup C mAb
NIBSC 96/528 Soluble Tumour Necrosis Factor Receptor Type 1, (Human, rDNA derived)
NIBSC 96/532 FMS-like tyrosine kinase 3 ligand (Human, rDNA derived) WHO Reference Reagent
NIBSC 96/534 Brain-derived Neurotrophic Factor (Human, rDNA derived) WHO Reference Reagent
NIBSC 96/538 Insulin-like growth Factor-II (Human rDNA derived) WHO Reference Reagent
NIBSC 96/556 Hepatocyte Growth Factor/Scatter Factor (precursor), (Human rDNA derived) WHO International Standard
NIBSC 96/564 Hepatocyte Growth Factor/Scatter Factor (Human, rDNA derived) WHO Reference Reagent
NIBSC 96/572 MAPREC analysis of Poliovirus type 3 (Sabin) Low virus reference 0.7%472-C WHO Reference Reagent
NIBSC 96/578 MAPREC analysis of Poliovirus type 3 (Sabin) High virus reference 1.1%472-C WHO Reference Reagent
NIBSC 96/602 Luteinizing Hormone, Human, recombinant WHO International Standard
NIBSC 96/784 Inhibin B, Human WHO Reference Reagent
NIBSC 96/836 Influenza Virus infectious RESVIR-9 (H3N2)
NIBSC 96/848 Influenza Virus infectious A/Shenzhen/227/95 (H1N1)
NIBSC 96/850 Influenza Virus infectious NIB-39 (H1N1)
NIBSC 97/518 Influenza Antigen A/Johannesburg/82/96
NIBSC 97/538 Anti-Granulocyte Macrophage Colony Stimulating Factor Serum
NIBSC 97/550 Islet Cell Antibodies WHO Reference Reagent
NIBSC 97/558 Bordetella pertussis anti 69kD serum (sheep)
NIBSC 97/562 Blood Coagulation Factors IXa Concentrate, Human, recombinant(1st I.S.)
NIBSC 97/564 Bordetella pertussis anti FHA serum (sheep)
NIBSC 97/572 Bordetella pertussis PT anti serum (sheep)
NIBSC 97/574 Bordetella pertussis anti Fim3 serum (sheep)
NIBSC 97/584 Influenza Antigen A/Equine/Newmarket/2/93
NIBSC 97/594 Leptin, Human, Recombinant WHO International Standard
NIBSC 97/596 Influenza Antigen A/Equine/Newmarket/1/93
NIBSC 97/600 Interleukin-2 Soluble Receptor (human, rDNA derived)
NIBSC 97/610 Influenza anti A/equine/Newmarket/1/93 Serum
NIBSC 97/612 Influenza anti- A/Nanchang/933/95 (H3N2) HA serum
NIBSC 97/614 Influenza anti A/Equine/Newmarket/2/93 (H3N8) HA Serum (SH-376)
NIBSC 97/626 Leptin, Mouse, Recombinant WHO International Standard
NIBSC 97/642 Bordetella pertussis anti serum (mouse) 1RR
NIBSC 97/646 Anti-Hepatitis A Immunoglobulin, Human (W1041) WHO International Standard
NIBSC 97/648 Anti-Measles serum (3rd International Standard)
NIBSC 97/692 Influenza Virus infectious IVR-108 (H3N2)
NIBSC 97/714 Prolactin, Human, recombinant. WHO Reference Reagent
NIBSC 97/722 Influenza Virus infectious A/duck/Sing-Q/119/97 (H5N3)
NIBSC 97/748 Influenza Antigen B/Harbin/7/94
NIBSC 97/756 MAPREC analysis of Poliovirus type 2 (Sabin), low virus reference 0.65%481-G. WHO Reference Reagent
NIBSC 97/758 MAPREC analysis of Poliovirus type 2 (Sabin) Synthetic DNA 0.67%481-G WHO International Standard
NIBSC 97/760 Influenza Antigen A/Beijing/262/95
NIBSC 98/524 MAPREC analysis of Poliovirus type 2 (Sabin) Synthetic DNA, 100%481-G WHO International Standard
NIBSC 98/544 Influenza Virus infectious RESVIR-13 (H3N2)
NIBSC 98/572 Diphtheria and Tetanus Antitoxin, Guinea Pig Serum
NIBSC 98/574 Somatropin WHO International Standard
NIBSC 98/580 Prolactin Human, recombinant, glycosylated WHO Reference Reagent
NIBSC 98/582 Prolactin, Human, recombinant, non-glycosylated WHO Reference Reagent
NIBSC 98/586 Calcitonin, Salmon. WHO International Standard
NIBSC 98/596 MAPREC analysis of Poliovirus type 2 (Sabin), high virus reference 1.21% 481-G. WHO Reference Reagent
NIBSC 98/600 Influenza Virus infectious NIB-40 (H5N3)
NIBSC 98/604 Influenza anti B/Harbin/7/94/HA Serum
NIBSC 98/610 Influenza Virus infectious ARIV-1 (H5N3)
NIBSC 98/666 Influenza anti A/Hong Kong/489/97 (H5N1) Serum (sheep)
NIBSC 98/686 Negative Control Guinea Pig Serum (Diphtheria and Tetanus Serology)
NIBSC 98/708 Haemiglobincyanide WHO International Standard
NIBSC 98/714 Tissue Plasminogen Activator, Human, Recombinant WHO International Standard
NIBSC 98/718 Neurotrophin 3
NIBSC 98/762 Influenza Virus infectious Resvir-14 (H3N2)
NIBSC 98/772 Influenza anti A/Beijing/262/95 Serum
NIBSC 98/774 Influenza Antigen B/Shangdong/7/97
NIBSC 98/778 Influenza Virus infectious A/Sichuan/346/98 (H3N2)
NIBSC 99/506 Anti-PT S1 subunit Monoclonal Antibody (1B7)
NIBSC 99/508 Anti-PT S1 subunit Monoclonal Antibody (1D7)
NIBSC 99/510 Anti-PT S1 subunit Monoclonal Antibody (3F11)
NIBSC 99/512 Anti-PT S1 subunit Monoclonal Antibody (10D6)
NIBSC 99/514 Anti-PT S1 subunit Monoclonal Antibody (8G4)
NIBSC 99/516 Anti-PT S1 subunit Monoclonal Antibody (E1E)
NIBSC 99/518 Anti-PT S1 subunit Monoclonal Antibody (E2E)
NIBSC 99/520 Anti-PT S1 subunit Monoclonal Antibody (3F10)
NIBSC 99/522 Anti-PT S1 subunit Monoclonal Antibody (11D9)
NIBSC 99/524 Anti-PT S1 subunit Monoclonal Antibody (4D10)
NIBSC 99/526 Anti-PT S23 subunit Monoclonal Antibody (11E6)
NIBSC 99/528 Anti-PT S23 subunit Monoclonal Antibody (10C9)
NIBSC 99/530 Anti-PT S23 subunit Monoclonal Antibody (10B5)
NIBSC 99/532 Anti-PT S23 subunit Monoclonal Antibody (G9A)
NIBSC 99/534 Anti-PT S23 subunit Monoclonal Antibody (3F6)
NIBSC 99/536 Anti-PT S2 subunit Monoclonal Antibody (3A12)
NIBSC 99/538 Anti-PT S2 subunit Monoclonal Antibody (2H3)
NIBSC 99/540 Anti-PT S2 subunit Monoclonal Antibody (9G8)
NIBSC 99/542 Anti-PT S3 subunit Monoclonal Antibody (7E10)
NIBSC 99/544 Anti-PT S3 subunit Monoclonal Antibody (7G11)
NIBSC 99/546 Anti-PT S3 subunit Monoclonal Antibody (4G5)
NIBSC 99/548 Anti-PT S3 subunit Monoclonal Antibody (2E12)
NIBSC 99/550 Anti-PT S3 subunit Monoclonal Antibody (6F8)
NIBSC 99/552 Anti-PT S3 subunit Monoclonal Antibody (10B8)
NIBSC 99/554 Anti-PT S4 subunit Monoclonal Antibody (7F2)
NIBSC 99/556 Anti-PT S4 subunit Monoclonal Antibody (6B3)
NIBSC 99/558 Anti-PT S4 subunit Monoclonal Antibody (6G8)
NIBSC 99/560 Anti-PT S4 subunit Monoclonal Antibody (9F3)
NIBSC 99/562 Anti-PT S4 subunit Monoclonal Antibody (1H2)
NIBSC 99/564 Anti-PT S4 subunit Monoclonal Antibody (9C6)
NIBSC 99/566 Anti-PT S4 subunit Monoclonal Antibody (6D6)
NIBSC 99/568 Anti-PT S5 subunit Monoclonal Antibody (7E3)
NIBSC 99/570 Anti Filamentous Haemagglutinin Monoclonal Antibody (1C6)
NIBSC 99/572 Anti-Filamentous Haemagglutinin Monoclonal Antibody (2E9)
NIBSC 99/574 Anti Filamentous Haemagglutinin Monoclonal Antibody (12G10)
NIBSC 99/586 Influenza Antigen B/Yamanashi/166/98
NIBSC 99/614 Influenza Antigen A/Sydney/5/97
NIBSC 99/616 Yellow Fever Vaccine. WHO International Standard
NIBSC 99/624 Influenza Antigen A/Sydney/5/97
NIBSC 99/642 Chorionic Gonadotrophin, nicked, human. WHO Reference Reagent
NIBSC 99/650 Chorionic Gonadotrophin, beta subunit, human. WHO Reference Reagent
NIBSC 99/666 Anti-HPA-5b (Minimum Potency) WHO Reference Reagent
NIBSC 99/674 HIV-2 (antibody) Monitor Sample
NIBSC 99/688 Chorionic Gonadatrophin, intact, Human. WHO Reference Reagent
NIBSC 99/692 Chorionic Gonadotrophin, nicked beta subunit, Human WHO Reference Reagent
NIBSC 99/706 Anti-Meningococcal human reference serum CDC1992
NIBSC 99/708 Chorionic Gonadatrophin, beta core fragment, Human WHO Reference Reagent
NIBSC 99/710 Anti-HIV 1 (1 in 5 BWS)
NIBSC 99/714 Influenza Antigen A/Singapore/1/57 (H2N2)
NIBSC 99/720 Chorionic Gonadotrophin, alpha subunit, Human (purified)
NIBSC 99/750 British Working Standard for Anti-HIV 1
NIBSC 99/824 Influenza Virus infectious RESVIR 16 (H3N2)
NIBSC 99/828 Influenza Antigen B/Yamanashi/166/98
NIBSC 99/836 Anti-D Minimum Potency Standard for blood grouping reagents WHO International Standard
NIBSC AFP Alpha-Foetoprotein. WHO International Standard
NIBSC B2M Beta-2 Microglobulin. WHO International Standard
NIBSC BUSB Botulinum Antitoxin Equine Type B. WHO International Standard
NIBSC CDS Anti-Canine Distemper Serum. WHO International Standard
NIBSC CHAN Cholera Antitoxin, Goat. WHO International Standard
NIBSC CHS Anti-Canine Hepatitis Serum
NIBSC COT Clostridium novyi (alpha) Toxoid. WHO Reference Reagent
NIBSC CWBETATD Clostridium Welchii (Perfringens)(Beta) Toxoid CwBT WHO Reference Reagent
NIBSC CWEPSILTD Clostridium Welchii (Perfringens) (Epsilon) toxoid
NIBSC DY Anti-Dysentery (shiga) serum, Equine. WHO International Standard
NIBSC HBOHA Lyophilised HBO-HA Antigen for ELISA, Lot 17
NIBSC JNIH-11 Bordetella pertussis anti FHA serum (mouse)
NIBSC JNIH-12 Bordetella pertussis PT( LPF) anti serum, (mouse)
NIBSC JNIH-3 Acellular Pertussis Vaccine - 1st IS.
NIBSC JNIH-4 Bordetella pertussis filamentous haemagglutinin (FHA)
NIBSC MEF/001 Primary Mouse Embryo Fibroblasts (p0)
NIBSC MGDS Anti-Mycoplasma gallisepticum Serum. WHO Reference Reagent
NIBSC NDS Anti-Newcastle Disease Serum. WHO International Standard
NIBSC NVIA Newcastle Disease Vaccine (Inactivated) WHO International Standard
NIBSC OE Gas Gangrene Antitoxin (Cl. novyi), Equine WHO International Standard
NIBSC PE Gas Gangrene Antitoxin (Cl. Perfringens alpha antitoxin) Equine WHO International Standard
NIBSC PPDA Purified Protein Derivative (PPD) of M Avium Tuberculin WHO International Standard
NIBSC PPDBOV Purified Protein Derivative (PPD) of Mycobacterium bovis Tuberculin (WHO 1st International Standard)
NIBSC PPDT Purified Protein Derivative (PPD) of M. Tuberculosis Tuberculin WHO International Standard
NIBSC QF Anti-Q Fever Serum, Bovine WHO International Standard
NIBSC RBT/16 Thromboplastin, Rabbit, Plain 5th International Standard 2016.
NIBSC RTF/16 Thromboplastin, Human, Recombinant, Plain 5th International Standard 2016.
NIBSC RUBI-1-94 Anti-rubella Immunoglobulin, Human WHO International Standard
NIBSC SES Swine Erysipelas Serum (anti-N) WHO Reference Reagent
NIBSC SFS Anti-Swine Fever Serum WHO International Standard
NIBSC SMV Smallpox Vaccine WHO International Standard
NIBSC SPDS-S2 Anti-Salmonella Pullorum Serum (Std. Form S) WHO International Standard
NIBSC SPDS-V Anti-Salmonella Pullorum Serum (Variant Form V) WHO International Standard
NIBSC SPLS Anti-Staphylococcal P-V Leucocidin serum, Equine WHO Reference Reagent
NIBSC SS-319/20 FITC CD4 Positive Control Cells
NIBSC SSCLOT5 SSC Secondary Coagulation Standard Lot#5
NIBSC STA Staphylococcus Alpha Antitoxin, Equine WHO International Standard
NIBSC STT Diphtheria (Schick) Test Toxin WHO International Standard
NIBSC TILI Anti-tick borne encephalitis serum (Louping Ill) WHO International Standard
NIBSC TISA Anti-tick borne encephalitis serum (Sophyn & Absettarov) WHO International Standard
NIBSC TYVK Typhoid Vaccine (acetone-inactivated) WHO International Standard
NIBSC TYVL Typhoid Vaccine (heat-phenol-inactivated) WHO International Standard
NIBSC VI Gas Gangrene Antitoxin (Cl. Septicum), Equine WHO International Standard
NIBSC W1004 Anti-C complete blood typing serum,human WHO International Standard
NIBSC W1005 Anti-E complete blood typing serum, human WHO International Standard
NIBSC W1007 Anti-c Incomplete blood typing serum, human WHO International Standard
NIBSC W1044 Anti-Varicella zoster immunoglobulin WHO International Standard
NIBSC W1062 Anti smooth muscle(anti actin) autoantibody. WHO Reference Reagent
NIBSC W1063 Anti nuclear ribonucleoprotein(nRNP) autoantibody WHO Reference Reagent
NIBSC W1064 Anti-Nuclear factor serum,homogenous(66/233)
NIBSC YF Anti-Yellow Fever Serum, monkey WHO Reference Reagent